| 1 | 1009119-64-5 | N,N'-[[1,1'-联苯]-4,4'-二基双[1H-咪唑-5,2-二基-(2S)-2,1-吡咯烷二基 [(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]双氨基甲酸 C,C'-二甲酯 | BMS-790052 | C40H50N8O6 | Daclatasvir (BMS-790052)是一种高度选择性的HCV NS5A抑制剂，EC50为9-50 pM，在细胞培养中，作用于多种HCV复制基因型和JFH-1基因型2a的感染性病毒。 |
| 2 | 101-89-3 | 固深红GBC 硫酸盐 | Fast Garnet GBC salt | C14H14N4O4S | |
| 3 | 103404-87-1 | 4-(2-羟乙基)-1-哌嗪乙烷磺酸半钠盐 | 4-(2-hydroxyethyl)piperazine-1-ethane-sulfon.ac. hemiso.S | C8H17N2NaO4S | |
| 4 | 110448-33-4 | 1-(5-碘萘-1-磺酰基)-1H-六氢-1,4-二氮杂卓盐酸盐 | 1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4 -diazepine, hydrochloride | C15H18ClIN2O2S | |
| 5 | 1163-36-6 | 盐酸氯咪唑 | clemizole hydrochloride | C19H21Cl2N3 | |
| 6 | 131543-23-2 | WIN 55,212-2甲磺酸盐 | WIN 55,212-2 MESYLATE | C28H30N2O6S | |
| 7 | 1328-51-4 | 溶剂蓝38 | Solvent Blue 38 | C32H12CuN8Na2O6S2 | |
| 8 | 1328-53-6 | 酞菁绿G | Phthalocyanine Green G | C32Cl16CuN8 | |
| 9 | 142326-59-8 | 7-氯-4-羟基-3-(3-苯氧基)苯基-2(1H)-喹啉 | L-701,324 | C21H14ClNO3 | |
| 10 | 146998-31-4 | 4-[4-(二甲基氨基)苯偶氮]苯甲酸 N-丁二酰亚胺酯 | 4-((4-(DIMETHYLAMINO)PHENYL)AZO)BENZOIC ACID, SUCCINIMIDYL ESTER | C19H18N4O4 | |
| 11 | 149003-01-0 | 盐酸右雷佐生 | Dexrazoxane hydrochloride | C11H16N4O4.ClH | |
| 12 | 154235-83-3 | 安帕来斯 | Ampalex | C14H15N3O | |
| 13 | 16208-51-8 | 地美司钠 | Dimesna | C4H8Na2O6S4 | |
| 14 | 163795-75-3 | SYBR绿色II核苷酸胶体染料 | sybr(R) green I nucleic acid gel stain | C32H37N4S | |
| 15 | 165377-44-6 | 1-(3,4-二甲氧基苯乙基)-4-(3-苯丙基)哌嗪双盐酸盐 | 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride | C23H32N2O2.2ClH | |
| 16 | 170098-38-1 | 爱维莫潘二水合物 | Alvimopan dihydrate | C25H36N2O6 | |
| 17 | 181632-25-7 | 6-氯-2,3-二氢-5-甲基-N-[6-[(2-甲基-3-吡啶基)氧]-3-吡啶基]-1H-吲哚-1-酰胺盐酸盐 | 6-Chloro-5-methyl-1-[[2-(2-methylpyrid-3-yloxy)pyrid-5-yl]carbamoyl]indoline hydrate dihydrochloride, 6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxyamide hydrate dihydrochloride | C21H19ClN4O2 | |
| 18 | 182004-65-5 | KB-R7943甲磺酰酸盐 | 2-[2-[4-(4-NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA MESYLATE | C17H21N3O6S2 | |
| 19 | 18378-20-6 | 4-苄氨基-7-硝基苯并-2-氧杂-1,3-二唑 | 7-Benzylamino-4-nitrobenz-2-oxa-1,3-diazole | C13H10N4O3 | |
| 20 | 185106-16-5 | 阿考替胺 | N-{2-[bis(1-methylethyl)amino]ethyl}-2-{[(2-hydroxy-4,5-dimethoxyphenyl)carbonyl]amino}-1,3-thiazole-4-carboxamide | C21H30N4O5S | |
| 21 | 1934-20-9 | 栀子黄色素 | Crocein Orange G | C16H11N2NaO4S | |
| 22 | 19608-29-8 | 21-羟基-17-(1-氧代丙氧基)孕甾-4-烯-3,20-二酮 | CB-03-01 | C24H34O5 | |
| 23 | 210282-30-7 | Fmoc-L-2-硝基苯丙氨酸 | Fmoc-L-2-Nitrophe | C24H20N2O6 | |
| 24 | 2150-48-3 | 派洛宁B | 3,6-bis(diethylamino)xanthylium chloride | C21H27Cl4FeN2O | |
| 25 | 2181-04-6 | 坎利酸钾 | canrenoic acid potassium | C11H15KO2 | |
| 26 | 241479-67-4 | 艾沙康唑 | Isavuconazole | C22H17F2N5OS | |
| 27 | 2516-05-4 | 亚甲紫 | Methylene Violet (Bernthsen) | C14H12N2OS | |
| 28 | 2538-85-4 | 铬蓝黑R | Palatine Chrome Black 6BN | C20H13N2NaO5S | |
| 29 | 27262-47-1 | 左布比卡因 | Levobupivacaine | C18H28N2O | |
| 30 | 27599-63-9 | 5(6)-氨基荧光素 | fluoresceinamine, mixture of isomers | C20H13NO5 | |
| 31 | 283173-50-2 | 8-氟-1,3,4,5-四氢-2-[4-[(甲基氨基)甲基]苯基]-6H-吡咯并[4,3,2-EF][2]苯并氮杂-6-酮 | 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]- | C19H18FN3O | |
| 32 | 3348-03-6 | 6-羧基荧光素二乙酸酯 | 6-carboxyfluorescein diacetate | C25H16O9 | |
| 33 | 34701-33-2 | (R)-4-甲基-3-戊胺 | (R)-4-Methyl-3-pentylamine | C5H13N | |
| 34 | 3618-63-1 | 媒介红7 | eriochrome red B | C20H15N4NaO5S | |
| 35 | 3624-68-8 | 酸性媒介兰9 | Mordant Blue 9 | C16H9ClN2Na2O8S2 | |
| 36 | 405911-09-3 | 3-[3-[[[2-氯-3-(三氟甲基)苯基]甲基](2,2-联苯基乙基)氨基]丙氧基]苯乙酸盐酸盐 | 2-[3-[3-[N-[2-Chloro-3-(trifluoromethyl)benzyl]-N-(2,2-diphenylethyl)amino]propoxy]phenyl]acetic acid | C33H31ClF3NO3 | |
| 37 | 453562-69-1 | 莫特塞尼 | Motesanib | C22H23N5O | |
| 38 | 496775-61-2 | 伊屈泼帕 | Eltrombopag | C25H22N4O4 | |
| 39 | 509088-69-1 | KRP-203 | KRP-203 | C24H27Cl2NO3S | |
| 40 | 51391-96-9 | 5-甲基盐酸环胞苷 | 5-Methylcyclocytidine hydrochlorine | C10H14ClN3O4 | |
| 41 | 541503-81-5 | 1-[(4,6-二甲基-5-嘧啶基)羰基]-4-[(3S)-4-[(1R)-2-甲氧基-1-[4-(三氟甲基)苯基]乙基]-3-甲基-1-哌嗪基]-4-甲基哌啶苹果酸盐 | vicriviroc malate | C32H44F3N5O7 | |
| 42 | 54375-47-2 | 钙黄绿素蓝 | 4-methylcoumarin-6-ylmethyliminodiacetic acid | C15H15NO7 | |
| 43 | 58969-01-0 | C.I.碱性紫14 | Basic Fuchsine | C20H20ClN3 | |
| 44 | 623142-96-1 | N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]-2-甲氧基苯基]-N'-[1-(2-噻唑基)乙基]脲 | N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]-2-methoxyphenyl]-N'-[1-(2-thiazolyl)ethyl]urea | C24H24N4O5S | |
| 45 | 6262-21-1 | 4,5,6,7-四氯荧光素 | 4,5,6,7-tetrachlorofluorescein | C20H8Cl4O5 | |
| 46 | 71145-03-4 | 氟硝尼啶 | Methyl 2,6-dimethyl-3-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-5-carboxylate | C16H15F3N2O4 | |
| 47 | 761423-87-4 | 依格列净 | Ipragliflozin | C21H21FO5S | |
| 48 | 76778-22-8 | 1-(2-乙基)-4-(3-苯丙基)哌嗪 | 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine | C28H34N2O | |
| 49 | 77172-72-6 | 3,4,5,6-四溴酚磺酞 | 3,4,5,6-Tetrabromophenolsulfonephthalein | C19H10Br4O5S | |
| 50 | 773092-05-0 | 盐酸阿考替胺三水合物 | Acotiamide hydrochloride trihydrate | C21H31ClN4O5S | |
| 51 | 82692-93-1 | N-乙基-N-(2-羟基-3-磺丙基)-3-甲基苯胺钠盐 | TOOS | C12H20NNaO4S | |
| 52 | 82692-96-4 | N-乙基-N-(2-羟基-3-磺丙基)-3-甲氧基苯胺钠二水合物 | ADOS | C12H22NNaO7S | |
| 53 | 82692-97-5 | N-乙基-N-(2-羟基-3-磺丙基)-3,5-二甲基苯胺钠盐一水合物 | N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethylaniline sodium salt monohydrate | C13H22NNaO5S | |
| 54 | 842133-18-0 | 坎格列净 | canagliflozin | 2(C24H25FO5S).H2O | |
| 55 | 85375-15-1 | 1-(4,4-二苯基-3-丁烯基)-3-哌啶盐酸盐 | N-(4,4-Diphenyl-3-butenyl)nipecotic acid hydrochloride | C22H26ClNO2 | |
| 56 | 861393-28-4 | A-740003 | Benzeneacetamide, N-[1-[[(cyanoamino)(5-quinolinylimino)methyl]amino]-2,2-dimethylpropyl]-3,4-dimethoxy- | C26H30N6O3 | |
| 57 | 865466-24-6 | 那拉匹韦 | Narlaprevir | C36H61N5O7S | |
| 58 | 869886-67-9 | 4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羟基乙基]-1H-吡咯-2-甲酰胺 | 4-[5-Chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide | C21H22Cl2N4O2 | |
| 59 | 91809-66-4 | 5-羧基四甲基罗丹明 | 5-Carboxytetramethylrhodamine | C25H22N2O5 | |
| 60 | 92623-85-3 | 米西普朗 | Milnacipran | C15H22N2O | |
| 61 | 945667-22-1 | 沙格列汀单水化合物 | Saxagliptin monohydrate | C18H27N3O3 | |
| 62 | 968-93-4 | 睾内酯 | testolactone | C19H24O3 | |
| 63 | 300842-64-2 | N-(3-溴-4-甲基苯基)-4-(4-吡啶甲基)-1-酞嗪胺 | ACC-789 | C21H17BrN4 | |
| 64 | 1228690-19-4 | 4'-[4-[[[(1R)-1-(2-氯苯基)乙氧基]羰基]氨基]-3-甲基-5-异恶唑基]-联苯-4-乙酸 | AM966 | C27H23ClN2O5 | |
| 65 | 1621862-70-1 | CPI-1205 | CPI-1205 | C27H33F3N4O3 | |
| 66 | 1672665-49-4 | PT2385 | PT2385 | C17H12F3NO4S | |
| 67 | 439575-02-7 | N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzamide | N-(5-((5-(4-Acetylpiperazine-1-carbonyl)-4-methoxy-2-methylphenyl)thio)thiazol-2-yl)-4-(((3,3-dimethylbutan-2-yl)amino)methyl)benzamide | C32H41N5O4S2 | |
| 68 | 146368-14-1 | cy5-NHS ester | cy5-NHS ester | C37H43N3O10S2 | |
| 69 | 960404-48-2 | 达格列嗪 | Dapagliflozin propanediol | C24H35ClO9 | |
| 70 | 307297-39-8 | 埃皮塔隆 | Epitalon | C14H22N4O9 | |
| 71 | 1401708-83-5 | Dihexa | Dihexa | C27H44N4O5 | |
| 72 | 913611-97-9 | 依匹哌唑 | Brexpiprazole | C25H27N3O2S | |
| 73 | 102212-26-0 | 2-((2-吡啶基甲基)氨基)苯酚 | ARN-2966 | C12H12N2O | |
| 74 | 1151516-14-1 | 阿斯利康钠盐 | RDEA-594 sodiuM | C17H13BrN3O2S.Na | |
| 75 | 82321-04-8 | 6-(2,4-二硝基苯胺基)己酸-N-琥珀酰亚氨基酯 | N-SUCCINIMIDYL 6-(2,4-DINITROANILINO)HEXANOATE | C16H18N4O8 | |
| 76 | 62758-12-7 | 乙基橙钠盐 | ETHYL ORANGE | C16H18N3NaO3S | |
| 77 | 4569-88-4 | 吲哚因蓝 | INDOINE BLUE | C30H24ClN5O | |
| 78 | 12627-53-1 | 瑞特染色剂 | LEISHMAN'S STAIN | | |
| 79 | 1481677-78-4 | 2-(4,4-二氟-1-哌啶基)-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基)丙氧基]-4-喹唑啉胺 | UNC-0642 | C29H44F2N6O2 | |
| 80 | 89889-52-1 | N-[6-(生物素氨基)己酰基]-6-氨基己酸N-琥珀酰亚胺酯 | BIOTIN-XX-NHS | C26H41N5O7S | |
| 81 | 1208313-97-6 | 酮酯 | Ketone Ester | C8H16O4 | |
| 82 | 1343-78-8 | 胭脂虫红 | Cochineal | C22H20O13 | |
| 83 | 4452-06-6 | 2-萘乙烯基酮 | ZM 449829 | C13H10O | |
| 84 | 76-12-0 | 1,2-二氟四氯乙烷 | 1,2-DIFLUOROTETRACHLOROETHANE | C2Cl4F2 | |
| 85 | 1081-71-6 | 4-羟基-3-甲氧基苯基丙酮酸 | 4-HYDROXY-3-METHOXYPHENYLPYRUVIC ACID | C10H10O5 | |
| 86 | 1297537-33-7 | S)-5-乙酰-N-(1-(3-(3-氯-4-氰基苯基)-1H-吡唑-1-基)丙-2-基)-1H-吡唑-3-甲酰胺 | (S)-5-acetyl-N-(1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-1H-pyrazole-3-carboxamide | C19H17ClN6O2 | Ketodarolutamide., also known as ORM-15341 and BAY-1896953, is a potent and full antagonist for human AR (hAR) with IC50 = 38 nM. Ketodarolutamide is a nonsteroidal antiandrogen (NSAA) and the major active metabolite of darolutamide (ODM-201, BAY-1841788), an NSAA which is used in the treatment of prostate cancer in men. Similarly to its parent compound, darolutamide acts as a highly selective, high-affinity, competitive silent antagonist of the androgen receptor (AR). Both agents show much higher affinity and more potent inhibition of the AR relative to the other NSAAs enzalutamide and apalutamide, although they also possess much shorter and comparatively less favorable elimination half-lives. |
| 87 | 144875-48-9 | 雷西莫特 | Resiquimod | C17H22N4O2 | |
| 88 | 1146-99-2 | 氯苯茚二酮 | 2-(4-CHLOROPHENYL)INDANE-1,3-DIONE | C15H9ClO2 | |
| 89 | 1446321-46-5 | 沃塞洛托 | Voxelotor | C19H19N3O3 | |
| 90 | 1297538-32-9 | 达洛鲁胺 | ODM-201 | C19H19ClN6O2 | |
| 91 | 1223405-08-0 | (3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐 | Larotrectinib sulfate | C21H24F2N6O6S | |
| 92 | 1420477-60-6 | 阿卡替尼 | Acalabrutinib | C26H23N7O2 | |
| 93 | 1942114-09-1 | EAI-045 | EAI-045 | C19H14FN3O3S | |
| 94 | 1421372-66-8 | AZD9291中间体1 | Mutated EGFR-IN-1 | C25H31N7O | |
| 95 | 857036-77-2 | 西地尼布马来酸盐 | Cediranib Maleate | C25H27FN4O3·C4H4O4 | |
| 96 | 1312445-63-8 | BKM120(盐酸盐) | NVP-BKM120 (Hydrochloride) | C18H22ClF3N6O2 | 简介 5-[2，6-二(4-吗啉基)-4-嘧啶基]-4-(三氟甲基)-2-吡啶胺，又名BKM120(盐酸盐)(Buparlisib)，是由诺华(Novartis)公司研发的乳腺癌新药。目前该药治疗转移性乳腺癌研究正处于III期临床和验证性I/II期临床阶段。 |
| 97 | 1256589-74-8 | 艾乐替尼盐酸盐 | 9-ethyl-6,6-diMethyl-8-(4-Morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride | C30H35ClN4O2 | |
| 98 | 760981-83-7 | 索利霉素 | Solithromycin | C43H65FN6O10 | |
| 99 | 1204669-58-8 | 艾卡哚司他 | Epacadostat | C11H13BrFN7O4S | |
| 100 | 1047645-82-8 | Afuresertib 盐酸盐 | GSK2110183B | C18H18Cl3FN4OS | |
| 101 | 1801747-42-1 | SHP-099游离 | SHP099 | C16H19Cl2N5 | |
| 102 | 1849590-01-7 | 6'-[(6-氨基-4-嘧啶基)氨基]-8'-甲基螺[环己烷-1,3'(2'H)-咪唑并[1,5-A]吡啶]-1',5'-二酮 | EFT-508 | C17H20N6O2 | |
| 103 | 1310726-60-3 | 乌帕替尼 | Upadacitinib | C17H19F3N6O | |
| 104 | 920509-32-6 | MGL-3196 | MGL-3196 | C17H12Cl2N6O4 | |
| 105 | 1219810-16-8 | GSH过氧化物酶4抑制剂(RSL3) | RSL3 | C23H21ClN2O5 | |
| 106 | 444606-18-2 | 度马莫得 | SB-681323 | C23H19F3N4O3 | |
| 107 | 1346242-81-6 | 厄达替尼 | ERDAFITINIB | C25H30N6O2 | |
| 108 | 1346547-00-9 | 6-[(叔丁基)磺酰基]-N-(5-氟-1H-吲唑-3-基)-4-喹啉胺 | 6-[(1,1-Dimethylethyl)sulfonyl]-N-(5-fluoro-1H-indazol-3-yl)-4-quinolinamine | C20H19FN4O2S | |
| 109 | 1123837-84-2 | 小分子抑制剂(SITRAVATINIB) | Sitravatinib | C33H29F2N5O4S | |
| 110 | 1123837-84-2 | CS-2638 | Sitravatinib | C33H29F2N5O4S | |
| 111 | 193884-53-6 | 9-(4'-氯苯硫代磷酰氧亚甲基)-10-甲基-9,10-二氢化吖啶二钠盐 | Disodium [(4-chlorophenyl)sulfanyl](10-methyl-9(10H)-acridinylidene)methyl phosphate | C21H15ClNO4PSNa2 | 用途 APS-5为白色粉末状物质， 主要用于化学发光底物的核心试剂。 |
| 112 | 202592-23-26 | (6S)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]噻唑并[4,3-A][1,4]二氮杂卓-6-乙酸 | 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-triMethyl-, (6S)- | C19H17ClN4O2S | |
| 113 | 1802220-02-5 | 洛普替尼 | TPX-0005 | C18H18FN5O2 | |
| 114 | 24730-31-2 | 表面活性素 | surfactin | C53H93N7O13 | |
| 115 | 733030-01-8 | 化合物TAS102 | Tipiracil hydrochloride-trifluridine mixt | C10H11F3N2O5. 1/2C9H11ClN4O2. | |
| 116 | 1228585-88-3 | 维沙莫德 | GS9620 | C22H30N6O2 | |
| 117 | 846557-71-9 | ML385 | ML385 | C31H29N3O2S | |
| 118 | 112093-28-4 | (Z)-N-去甲基-4-羟基三苯氧胺 | Endoxifen | C25H27NO2 | |
| 119 | 249921-19-5 | 阿拉莫林 | Anamorelin | C31H42N6O3 | |
| 120 | 1118567-05-7 | (1S)-1,5-脱水-1-C-[4-氯-3-[[4-[2-(环丙氧基)乙氧基]苯基]甲基]苯基]-D-山梨醇 | EGT1442 | C24H29ClO7 | |
| 121 | 1192500-31-4 | 阿维巴坦游离酸 | AvibactaM | C7H11N3O6S | 用途 阿维巴坦中间体。 |
| 122 | | 交联葡聚糖凝胶G-75 | Cross-linked dextran gel G-75 | | |
| 123 | 1445993-26-9 | 米维布塞 | ABBV-075 | C22H19F2N3O4S | |
| 124 | 728865-23-4 | CHIR 090 | CHIR-090 | C24H27N3O5 | |
| 125 | 253449-04-6 | WISKOSTATIN | 1-(3,6-DIBROMO-9H-CARBAZOL-9-YL)-3-(DIMETHYLAMINO)PROPAN-2-OL | C17H18Br2N2O | 用途 一种选择性的N-wasp抑制剂。Wiskostatin is a selective inhibitor of N-WASP, a ubiquitously expressed member of the Wiskott-Aldrich Syndrome protein (WASp) family that regulates actin polymerization. Wiskostatin inhibits actin-dependent cellular functions, including migration, transmembrane transport and phagocytosis. |
| 126 | 57333-96-7 | 他卡西妥 | Tacalcitol | C27H44O3 | |
| 127 | 956-48-9 | 2,6-二氯靛酚 | 2,6-dichlorophenolindophenol | C12H7NO2Cl2 | 用途 一般常用作维生素C的测定。 |
| 128 | 148504-34-1 | 钙黄绿素乙酰甲酯 | CALCEIN-AM | C46H46N2O23 | |
| 129 | 11016-15-2 | 藻蓝蛋白 | C-PHYCOCYANIN | | |
| 130 | 150347-59-4 | 5(6)-羧基二乙酸荧光素琥珀酰亚胺酯 | 5(6)-(N-SUCCINIMIDYLOXYCARBONYL)-3',6',O,O'-DIACETYLFLUORESCEIN | C29H19O11 | |
| 131 | 113558-14-8 | 大花淫羊藿苷F | Ikarisoside F | C31H36O14 | |
| 132 | 107390-08-9 | 伽升沃 D | garcinone D | C24H28O7 | |
| 133 | 53185-12-9 | 荞麦碱 | Fagomine | C6H13NO3 | |
| 134 | 174022-42-5 | Bevirimat | Bevirimat | C36H56O6 | |
| 135 | 68027-15-6 | 白头翁皂苷D | Pulsatillasaponin D | C47H76O17 | |
| 136 | 113973-31-2 | (Z)-阿枯米定碱 | (Z)-Akuammidine | C21H24N2O3 | |
| 137 | 89590-98-7 | 罗汉果苷VI | Mogroside VI | C66H112O34 | |
| 138 | 183321-86-0 | OSI-420Free Base | OSI-420, Free Base (Desmethyl Erlotinib) | C21H21N3O4 | |
| 139 | 58471-53-7 | H-ASP-ASP-OH | H-ASP-ASP-OH | C8H12N2O7 | |
| 140 | 15483-27-9 | H-ARG-ARG-OH | H-ARG-ARG-OH ACETATE SALT | C12H26N8O3 | |
| 141 | 1258296-60-4 | RO495 | RO495 | C17H14Cl2N6O | |
| 142 | 344940-63-2 | Diphenylterazine | Diphenylterazine | C25H19N3O | |
| 143 | 865231-46-5 | (S)-3-(4-((4'-(Trifluoromethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)hex-4-ynoic acid | (S)-3-(4-((4'-(Trifluoromethyl)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)hex-4-ynoic acid | C26H21F3O3 | |
| 144 | 1217644-25-1 | 3-Amino-5-methoxy-1H-indole-2-carboxylic acidethyl ester | 3-Amino-5-methoxy-1H-indole-2-carboxylic acidethyl ester | C19H19NO5 | |
| 145 | 57407-08-6 | DEAE琼脂糖凝胶FF | DEAE-Sepharose | | |
| 146 | 3625-57-8 | 耐尔蓝A | Nile Blue A | C20H20N3O5S- | |
| 147 | 7423-31-6 | 着色剂-ALL | Stains-All | C30H27BrN2S2 | |
| 148 | 74515-25-6 | 6-十二酰基-N,N-二甲基-2-萘胺 | LAURDAN | C24H35NO | |
| 149 | 199745-67-0 | Texas Red-X,SE | Texas Red-X,SE | C37H41N3O8S2 | |
| 150 | 153587-01-0 | NS-1619 | NS 1619 | C15H8F6N2O2 | |
| 151 | 13636-18-5 | 盐酸芬他林 | FENDILINE HYDROCHLORIDE | C23H26ClN | |
| 152 | 62851-42-7 | 哲纳尔氏染色素 | JENNER'S STAIN | 62851-42-7 | |
| 153 | 119171-73-2 | 10-乙酰基-3,7-二羟基吩噁嗪 | [10-Acetyl-3,7-dihydroxyphenoxazine] | C14H11NO4 | |
| 154 | 68683-34-1 | 二牛磺酸胆红素钠盐 | Bilirubin conjugate | C37H44N6Na2O10S2 | |
| 155 | 186689-07-6 | 2-(N-7-硝基-2,1,3-苯并恶二唑-4-氨基)-2-脱氧-D-葡萄糖 | 2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose | C12H14N4O8 | |
| 156 | 1448346-63-1 | AG-120 Racemate | AG-120 Racemate | C28H22ClF3N6O3 | |
| 157 | 1392116-14-1 | JD-5037 | (S)-2-(((E)-((S)-3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazol-1-yl)((4-chlorophenyl)sulfonamido)methylene)amino)-3-methylbutanamide | C27H27Cl2N5O3S | |
| 158 | 519187-97-4 | Edonerpic maleate | Edonerpic maleate | C20H25NO6S | |
| 159 | 124387-19-5 | 5(6)-羧基荧光素二乙酸酯 | 5(6)-Carboxy-di-O-acetylfluorescein | C50H32O18 | 用途 一种荧光探针，在诸如流式细胞仪分析应用中用于细胞染色。 |
| 160 | 866405-64-3 | 6-[4-[2-(1-哌啶基)乙氧基]苯基]-3-(4-吡啶基)吡唑并[1,5-A]嘧啶 | Dorsomorphin | C24H25N5O | |
| 161 | 130497-33-5 | 2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylmethyl)-piperidin-1-yl)ethanone hydrochloride | 2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylmethyl)piperidin-1-yl)ethanone hydrochloride | C18H24Cl2N2O | |
| 162 | 5786-68-5 | Quipazine Maleate | Quipazine Maleate | C17H19N3O4 | |
| 163 | 199113-98-9 | Balaglitazone | Balaglitazone | C20H17N3O4S | |
| 164 | 26993-30-6 | D-苏式-鞘胺醇-1-磷酸 | D-erythro-sphingosine-1-phosphate | C18H38NO5P | A ligand for EDG-1 and EDG-3 and activator of GPR3, GPR6, and GPR12. |
| 165 | 65646-68-6 | Fenretinide | Fenretinide | C26H33NO2 | |
| 166 | 1242933-88-5 | Fmoc-Lys(5-FAM)-OH | Fmoc-Lys(5-FAM)-OH | C42H34N2O10 | |
| 167 | 300815-41-2 | RS 102895 | RS 102895 | C21H21F3N2O2 | |
| 168 | 649749-10-0 | 四硫钼酸二胆碱 | Bis(choline)tetrathioMolybdate | C10H28MoN2O2S4 | |
| 169 | 1005264-47-0 | MX69 | MX69 | C27H26N2O4S | |
| 170 | 1009820-21-6 | CX-4945 (Silmitasertib) | CX-4945 (Silmitasertib) | C19H12ClN3O2 | |
| 171 | 1047634-65-0 | GSK2141795 | GSK2141795 | C18H16Cl2F2N4O2 | |
| 172 | 1137359-47-7 | BRD7552 | BRD7552 | C33H33N3O15 | |
| 173 | 1164470-53-4 | Sal003 | (E)-1-(4-chlorophenyl)-3-(1,1,1-trichloro-4-oxo-6-phenylhex-5-en-2-yl)thiourea | C18H15Cl4N3OS | |
| 174 | 1173699-31-4 | AMG-337 | AMG-337 | C23H22FN7O3 | |
| 175 | 118414-82-7 | MK-886 | MK-886 | C27H34ClNO2S | |
| 176 | 1203494-49-8 | DASA-58 | DASA-58 | C19H23N3O6S2 | |
| 177 | 1228013-15-7 | CC-115 | CC-115 | C16H16N8O | |
| 178 | 1232030-35-1 | FRAX486 | FRAX486 | C25H23Cl2FN6O | |
| 179 | 1234480-46-6 | XMD8-87 | XMD8-87 | C24H27N7O2 | |
| 180 | 1238697-26-1 | TAK-063 | TAK-063 | C23H17FN6O2 | |
| 181 | 1265965-22-7 | S49076 | S49076 | C22H22N4O4S | |
| 182 | 1286770-55-5 | Verubecestat | Verubecestat | C17H17F2N5O3S | |
| 183 | 130495-35-1 | SKF-96365 (hydrochloride) | 1-(2-(4-methoxyphenyl)-2-(3-(4-methoxyphenyl)propoxy)ethyl)-1H-imidazole hydrochloride | C22H27ClN2O3 | |
| 184 | 1313363-54-0 | NVP-CGM097 | (S)-1-(4-chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4S)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,2-dihydroisoquinolin-3(4H)-one | C38H47ClN4O4 | |
| 185 | 1338545-07-5 | OTS-964 | OTS-964 | C23H24N2O2S | |
| 186 | 134381-21-8 | Epoxomicin | Epoxomicin | C28H50N4O7 | |
| 187 | 1345098-78-3 | XMD16-5 | XMD16-5 | C23H24N6O2 | |
| 188 | 136553-81-6 | BQ-123 SODIUM SALT | BQ-123 SODIUM SALT | C31H42N6O7 | |
| 189 | 141400-58-0 | PX-12 | PX-12 | C7H12N2S2 | |
| 190 | 1415560-69-8 | Crizotinib (hydrochloride) | Crizotinib (hydrochloride) | C21H23Cl3FN5O | |
| 191 | 1419949-20-4 | NVP-TNKS656 | NVP-TNKS656 | C27H34N4O5 | NVP-TNKS656 is a highly potent, selective, and orally active TNKS2 inhibitor. |
| 192 | 1429639-50-8 | CZ415 | CZ415 | C22H29N5O4S | |
| 193 | 1439399-58-2 | CB-839 | CB-839 | C26H24F3N7O3S | |
| 194 | 1453848-26-4 | GDC-0994 | GDC-0994 | C21H18ClFN6O2 | |
| 195 | 1469924-27-3 | N'-[4'-(二甲基氨基)[1,1'-联苯]-3-基]-N,N-二甲基脲 | Atglistatin | C17H21N3O | |
| 196 | 1515856-92-4 | XEN445 | XEN445 | C18H17F3N2O3 | |
| 197 | 157654-67-6 | NSC 632839 | NSC 632839 | C21H21NO.ClH | |
| 198 | 159182-43-1 | L755,507 | 4-[[(HEXYLAMINO)CARBONYL]AMINO]-N-[4-[2-[[(2S)-2-HYDROXY-3-(4-HYDROXYPHENOXY)PROPYL]AMINO]ETHYL]PHENYL]-BENZENESULFONAMIDE | C30H40N4O6S | |
| 199 | 1604810-83-4 | THZ1 | THZ1 | C31H28ClN7O2 | |
| 200 | 1609960-30-6 | TH287 | TH287 | C11H10Cl2N4 | |
| 201 | 1609960-31-7 | TH588 | TH588 | C13H12Cl2N4 | |
| 202 | 1624602-30-7 | VR23 | VR23 | C19H16ClN5O6S | |
| 203 | 1627494-13-6 | AZD8186 | AZD8186 | C24H25F2N3O4 | |
| 204 | 1627709-94-7 | LJI308 | LJI308 | C21H18F2N2O2 | |
| 205 | 1639042-08-2 | AZD9496 | AZD9496 | C25H25F3N2O2 | |
| 206 | 1668553-26-1 | A-1210477 | Abbvie Mcl-1 Inhibitor | C46H55N7O7S | |
| 207 | 1675201-83-8 | (S)-1-(2,6-二甲氧基-4-((2-甲基-[1,1'-联苯]-3-基)甲氧基)苄基)哌啶-2-甲酸 | PD1-PDL1 inhibitor 1 | C29H33NO5 | |
| 208 | 1675203-84-5 | BMS-202 | BMS-202 | C25H29N3O3 | |
| 209 | 170787-99-2 | Efaproxiral sodium | Efaproxiral sodium | C20H22NNaO4 | |
| 210 | 176957-55-4 | CCT007093 | CCT007093 | C15H12OS2 | |
| 211 | 1799753-84-6 | BAY-876 | BAY-876 | C24H16F4N6O2 | |
| 212 | 1802088-50-1 | NCT-501 | NCT-501 | C21H32N6O3 | |
| 213 | 187235-37-6 | (S)-PA 824 | (S)-PA 824 | C14H12F3N3O5 | |
| 214 | 1884220-36-3 | SBI-0206965 | SBI-0206965 | C21H21BrN4O5 | |
| 215 | 1956356-56-1 | KYA1797K | KYA1797K | C17H11KN2O6S2 | |
| 216 | 200626-61-5 | ITSA-1 | Benzotriazol-1-yl-(2,4-Dichloro-Phenyl)-Methanone | C13H7Cl2N3O | |
| 217 | 215543-92-3 | SU 5402 | SU 5402 | C17H16N2O3 | |
| 218 | 218156-96-8 | SRPIN340 | SRPIN340 | C18H18F3N3O | |
| 219 | 218924-25-5 | KNK437 | KNK437 | C13H11NO4 | |
| 220 | 222638-67-7 | BEC hydrochloride | S-(2-boronoethyl)-L-cysteine hydrochloride | C5H13BClNO4S | |
| 221 | 223104-29-8 | SEA0400 | SEA0400 | C21H19F2NO3 | |
| 222 | 293754-55-9 | T0901317 | T0901317 | C17H12F9NO3S | |
| 223 | 300586-90-7 | OAC1 | OAC1 | C14H11N3O | |
| 224 | 301353-96-8 | P7C3 | 1-(3,6-Dibromo-carbazol-9-yl)-3-phenylamino-propan-2-ol | C21H18Br2N2O | |
| 225 | 305834-79-1 | SC79 | 2-Amino-6-chloro-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic Acid Ethyl Ester | C17H17ClN2O5 | |
| 226 | 315704-66-6 | PTC-209 | PTC-209 | C17H13Br2N5OS | |
| 227 | 315706-13-9 | 4EGI-1 | 4EGI-1 | C18H12Cl2N4O4S | |
| 228 | 328541-79-3 | GlyH-101 | N-2-Naphthalenyl-glycine 2-[(3,5-Dibromo-2,4-dihydroxyphenyl)methylene]hydrazide | C19H15Br2N3O3 | |
| 229 | 328998-25-0 | 4E1RCat | (E)-4-(3-((5-(4-Nitrophenyl)furan-2-yl)methylene)-2-oxo-5-phenyl-2,3-dihydro-1H-pyrrol-1-yl)benzoic | C28H18N2O6 | |
| 230 | 342639-96-7 | KRIBB11 | KRIBB11 | C13H12N6O2 | |
| 231 | 345630-40-2 | SF1670 | SF1670 | C19H17NO3 | |
| 232 | 348086-71-5 | BAY 57-1293 | BAY 57-1293 | C18H18N4O3S2 | |
| 233 | 349085-38-7 | HC-030031 | HC-030031 | C18H21N5O3 | |
| 234 | 431898-65-6 | PS-1145 | N-(6-CHLORO-9H-PYRIDO[3,4-B]INDOL-8-YL)-3-PYRIDINECARBOXAMIDE DIHYDROCHLORIDE | C17H11ClN4O | |
| 235 | 459147-39-8 | SW033291 | SW033291 | C21H20N2OS3 | |
| 236 | 472981-92-3 | N-(4-Methoxyphenyl)-4-chlorocinnamamide | (E)-3-(4-chlorophenyl)-N-(3-methoxyphenyl)acrylamide | C16H14ClNO2 | |
| 237 | 52029-86-4 | STO-609 | 7-Oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic Acid | C19H10N2O3 | |
| 238 | 521937-07-5 | CID755673 | 3-Hydroxy-5,6,7,8-tetrahydro-10-oxa-8-aza-benzo[a]azulen-9-one | C12H11NO3 | |
| 239 | 75350-46-8 | 荧光素5-马来酰亚胺 | Fluorescein-5-Maleimide | C24H13NO7 | |
| 240 | 803647-40-7 | NSC59984 | NSC59984 | C12H15N3O4 | |
| 241 | 81624-55-7 | NSC348884 | NSC348884 | C38H40N10 | |
| 242 | 839706-07-9 | GNF-7 | BenzaMide, N-[3-[1,4-dihydro-1-Methyl-7-[(6-Methyl-3-pyridinyl)aMino]-2-oxopyriMido[4,5-d]pyriMidin-3(2H)-yl]-4-Methylphenyl]-3-(trifluoroMethyl)- | C28H24F3N7O2 | |
| 243 | 853220-52-7 | BML-284 | BML-284 | C19H18N4O3 | |
| 244 | 854107-55-4 | Ponesimod ( ACT-128800) | (2Z,5Z)-5-(3-chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propyliMino)-3-(o-tolyl)thiazolidin-4-one | C23H25ClN2O4S | |
| 245 | 875787-07-8 | LXR-623 ( WAY 252623) | 2H-Indazole, 2-[(2-chloro-4-fluorophenyl)Methyl]-3-(4-fluorophenyl)-7-(trifluoroMethyl)- | C21H12ClF5N2 | |
| 246 | 890128-81-1 | BFH772 | BFH772 | C23H16F3N3O3 | |
| 247 | 896720-20-0 | VX-11e | VX-11e | C24H20Cl2FN5O2 | |
| 248 | 911417-87-3 | SLx-2119 | SLx-2119 | C26H24N6O2 | |
| 249 | 912545-86-9 | SAG | SAG | C28H28ClN3OS | |
| 250 | 918633-87-1 | TH-302 | TH-302 | C9H16Br2N5O4P | |
| 251 | 939981-39-2 | RG7112 | RG7112 | C38H48Cl2N4O4S | |
| 252 | 1047953-91-2 | MI 2 (MALT1 inhibitor) | 2-chloro-N-(4-(5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1H-1,2,4-triazol-1-yl)phenyl)acetamide | C19H17Cl3N4O3 | MI-2 MALT1 inhibitor, also known as MI-2, is a MALT1 inhibitor (IC50 = 5.84 μM). MI-2 binds directly to MALT1 and irreversibly suppresses protease function. Decreases NF-κB activity induced by MALT1. Mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1 (MALT1), a paracaspase and essential regulator for nuclear factor kB (NF-κB) activation, plays an important role in innate and adaptive immunity. Suppression of MALT1 protease activity with small molecule inhibitors showed promising efficacies in subtypes of B cell lymphoma and improvement in experimental autoimmune encephalomyelitis model. |
| 253 | 1096708-71-2 | MLN2480 | MLN2480 | C17H12Cl2F3N7O2S | |
| 254 | 1140964-99-3 | E7449 | E7449 | C18H15N5O | |
| 255 | 1163719-56-9 | CCT196969 | CCT196969 | C27H24FN7O3 | |
| 256 | 1190378-57-4 | MRT67307 | MRT67307 | C26H36N6O2 | |
| 257 | 1194961-19-7 | PRT-060318 | PRT-060318 | C18H24N6O | |
| 258 | 1206799-15-6 | LY2801653 | LY2801653 | C30H22F2N6O3 | |
| 259 | 1207293-36-4 | BI-847325 | BI-847325 | C29H28N4O2 | |
| 260 | 1218942-37-0 | GKT137831 | GKT137831 | C21H19ClN4O2 | |
| 261 | 1221713-92-3 | NPS-1034 | N-(3-fluoro-4-((3-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)phenyl)-2-(4-fluorophenyl)-1,5-dimethyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxamide. | C31H23F2N5O3 | |
| 262 | 1224887-10-8 | GSK2256098 | GSK2256098 | C20H23ClN6O2 | |
| 263 | 1229582-33-5 | URMC-099 | URMC-099 | C27H27N5 | |
| 264 | 1234015-54-3 | LY2606368 (dihydrochloride) | LY2606368 (dihydrochloride) | C18H21Cl2N7O2 | |
| 265 | 125314-13-8 | CP21R7 | CP21R7 | C19H15N3O2 | |
| 266 | 1253952-02-1 | Netarsudil (AR-13324) 2HCl | Netarsudil (AR-13324) 2HCl | C28H29Cl2N3O3 | |
| 267 | 1290541-46-6 | RAD51 Inhibitor B02 | RAD51 Inhibitor B02 | C22H17N3O | |
| 268 | 1290543-63-3 | PF-3084014 | PF-3084014 | C27H41F2N5O | |
| 269 | 1334493-07-0 | BP-1-102 | BP-1-102 | C29H27F5N2O6S | |
| 270 | 1338806-73-7 | CFI-400945 (free base) | CFI-400945 (free base) | C33H34N4O3 | |
| 271 | 1351635-67-0 | ONO-4059 (analog) | ONO-4059 (analog) | C25H24N6O3 | |
| 272 | 1357470-29-1 | ON123300 | ON123300 | C24H27N7O | |
| 273 | 1360614-48-7 | N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺 | Necrosulfonamide | C18H15N5O6S2 | (E)-Necrosulfonamide is an inhibitor of necroptosis. Blocks mixed lineage kinase domain-like protein (MLKL), a critical substrate of receptor-interacting serine-threonine kinase 3 (RIP3) during necrosis. Prevents MLKL-RIP1-RIP3 necrosome complex from interacting with downstream necrosis effectors. Binds and inhibits gasdermin D. Inhibits pyroptosis. |
| 274 | 1373422-53-7 | GSK-J1 | GSK-J1 | C22H23N5O2 | |
| 275 | 1420071-30-2 | Bioymifi | Bioymifi | C22H12BrN3O4S | |
| 276 | 1429749-41-6 | Thiomyristoyl | Thiomyristoyl | C34H51N3O3S | |
| 277 | 1429881-91-3 | UNC2025 | UNC2025 | C28H40N6O | |
| 278 | 1430844-80-6 | A-1331852 | A-1331852 | C38H38N6O3S | |
| 279 | 1431697-89-0 | OTSSP167 | OTSSP167 | C25H28Cl2N4O2 | |
| 280 | 1454682-72-4 | LY3009120 | LY3009120 | C23H29FN6O | |
| 281 | 1474034-05-3 | RTA-408 | RTA-408 | C33H44F2N2O3 | |
| 282 | 1527473-33-1 | PF-06447475 | PF-06447475 | C17H15N5O | |
| 283 | 1532533-67-7 | TGR-1202 | TGR-1202 | C31H24F3N5O3 | |
| 284 | 1550008-55-3 | ML264 | ML264 | C17H21ClN2O4S | |
| 285 | 1594092-37-1 | AZ191 | AZ191 | C24H27N7O | |
| 286 | 1608125-21-8 | AMG 319 | AMG319 | C21H16FN7 | |
| 287 | 1609402-14-3 | HA15 | N-(4-(3-((5-(dimethylamino)naphthalene)-1-sulfonamido)phenyl)thiazol-2-yl)acetamide | C23H22N4O3S2 | |
| 288 | 1613724-42-7 | HTH-01-015 | HTH-01-015 | C26H28N8O | |
| 289 | 1619994-68-1 | GSK2801 | GSK2801 | C20 H21 N O4 S | |
| 290 | 1622849-58-4 | GSK481 | 5-(phenylmethyl)-N-[(3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl]-3-isoxazolecarboxamide | C21H19N3O4 | |
| 291 | 1628208-23-0 | CPI-455 | CPI-455； 6-isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile | C16H14N4O | CPI-455 是一种特异性的泛 KDM5 抑制剂，对 KDM5A 的 IC50 为 10 nM，CPI-455 介导 KDM5 抑制，提高 H3K4me3 的整体水平，并减少多肿瘤细胞系模型中耐药的持久癌细胞的数量。 |
| 292 | 1628316-74-4 | MI-136 | 5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile | C23H21F3N6S | |
| 293 | 1629268-00-3 | ARS-853 | ARS-853 | C22H29ClN4O3 | |
| 294 | 1637739-82-2 | BQU57 | BQU57 | C16H13F3N4O | |
| 295 | 1642300-52-4 | KPT-8602 | KPT-8602 | C17H10F6N6O | |
| 296 | 1687736-54-4 | SGC707 | SGC707 | C16H18N4O2 | |
| 297 | 1714146-59-4 | I-BRD9 | I-BRD9 | C22H22F3N3O3S2 | |
| 298 | 181223-80-3 | DEL-22379 | DEL-22379 | C26H28N4O3 | |
| 299 | 1857417-13-0 | MI-503 | 4-Methyl-1-(1H-pyrazol-4-ylmethyl)-5-[[4-[[6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1H-indole-2-carbonitrile | C28H27F3N8S | |
| 300 | 1910124-24-1 | GSK6853 | GSK6853 | C22H27N5O3 | |
| 301 | 193551-21-2 | SB 239063 | SB 239063 | C20H21FN4O2 | |
| 302 | 2002381-31-7 | APS-2-79 (hydrochloride) | APS-2-79 (hydrochloride) | C23H22ClN3O3 | |
| 303 | 252017-04-2 | AZD7545 | AZD7545 | C19H18ClF3N2O5S | |
| 304 | 263707-16-0 | ESI-09 | ESI-09 | C16H15ClN4O2 | |
| 305 | 288250-47-5 | Y-320 | 1-(4-Chlorophenyl)-N-(3-cyano-4-(4-morpholinopiperidin-1-yl)phenyl)-5-methyl-1H-pyrazole-4-carboxami | C27H29ClN6O2 | |
| 306 | 307543-71-1 | STF 083010 | STF 083010 | C15H11NO3S2 | |
| 307 | 312756-74-4 | 4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺 | 4-Bromo-N-(4-bromophenyl)-3-[[(phenylmethyl)amino]sulfonyl]benzamide | C20H16Br2N2O3S | |
| 308 | 346640-08-2 | CCF642 | CCF642 | C15H10N2O4S3 | |
| 309 | 413611-93-5 | 10074-G5 | N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine | C18H12N4O3 | |
| 310 | 436133-68-5 | Kobe0065 | N-(3-Chloro-4-methylphenyl)-2-[2,6-dinitro-4-(trifluoromethyl)phenyl]-hydrazinecarbothioamide | C15H11ClF3N5O4S | |
| 311 | 476310-60-8 | VO-Ohpic trihydrate | (OC-6-45) Aqua (3-hydroxy-2-pyridinecarboxylato-kapaN1,kapaO2)[3-(hydroxy-kapaO)-2-pyridinecarboxylato(2-)-kapaO2]oxo-vanadate(1-), hydrogen, trihydrate | C12H8N2O7V.3H2O | |
| 312 | 491833-29-5 | Eliglustat | Eliglustat | C23H36N2O4 | |
| 313 | 522629-08-9 | CGP 57380 | CGP 57380 | C11H9FN6 | |
| 314 | 629664-81-9 | Turofexorate isopropyl | 3-(3,4-Difluorobenzoyl)-1,2,3,6-tetrahydro-1,1-dimethylazepino[4,5-b]indole-5-carboxylic acid 1-methylethyl ester | C25H24F2N2O3 | |
| 315 | 6501-72-0 | VGX-1027 ( GIT 27) | 2-(3-Phenyl-4,5-dihydroisoxazol-5-yl)acetic Acid | C11H11NO3 | |
| 316 | 659730-32-2 | Amg 517 | Amg 517 | C20H13F3N4O2S | |
| 317 | 817194-38-0 | GSK180736A | GSK180736A | C19H16FN5O2 | |
| 318 | 836620-48-5 | AS1842856 | AS1842856 | C18H22FN3O3 | |
| 319 | 895158-95-9 | SC144 | SC144 | C16H11FN6O | |
| 320 | 899805-25-5 | CC-930 | CC-930 | C21H23F3N6O2 | |
| 321 | 924416-43-3 | AdipoRon | AdipoRon | C27H28N2O3 | |
| 322 | 926259-99-6 | BG45 | BG45 | C11H10N4O | |
| 323 | 926927-61-9 | Motolimod | Motolimod | C28H34N4O2 | |
| 324 | 927822-86-4 | KC7F2 | KC7F2 | C16H16Cl4N2O4S4 | |
| 325 | 934493-76-2 | SAR245409 | SAR245409 | C13H14N6O | |
| 326 | 942206-85-1 | GSK1016790A | GSK1016790A | C28H32Cl2N4O6S2 | |
| 327 | 946128-88-7 | Ro 5126766 | Ro 5126766 | C21H18FN5O5S | |
| 328 | 1000787-75-6 | Tegobuvir | Tegobuvir | C25H14F7N5 | |
| 329 | 1001288-58-9 | FT011 | FT011 | C20H17NO5 | |
| 330 | 1005491-05-3 | 1-(1-乙基丙基)-6-乙炔基-1,3-二氢-2H-咪唑并[4,5-B]吡嗪-2-酮 | Tirasemtiv | C12H14N4O | |
| 331 | 1005780-62-0 | TAK-593 | TAK-593 | C23H23N7O3 | |
| 332 | 1006036-87-8 | MK-2894 | MK-2894 | C25H22F3NO3S | |
| 333 | 1011301-27-1 | Tenovin-3 | Tenovin-3 | C18H21N3OS | |
| 334 | 1019331-10-2 | S0859 | S0859 | C29H24ClN3O3S | |
| 335 | 1020315-31-4 | PF-04457845 | PF-04457845 | C23H20F3N5O2 | |
| 336 | 102121-60-8 | AM580 | 4-[(5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-2-Naphthalenyl)Carboxamido]Benzoic Acid | C22H25NO3 | |
| 337 | 1032229-33-6 | A939572 | A939572 | C20H22ClN3O3 | |
| 338 | 1033836-12-2 | HPGDS inhibitor 1 | HPGDS inhibitor 1 | C19H19F4N3O | |
| 339 | 1037792-44-1 | MBX-2982 | MBX-2982 | C22H24N8OS | |
| 340 | 1042672-97-8 | IRAK inhibitor 6 | IRAK inhibitor 6 | C20H20N4O3S | |
| 341 | 107257-28-3 | PK14105 | PK14105 | C21H20FN3O3 | |
| 342 | 1088991-73-4 | MK-6096 | MK-6096 | C24H25FN4O2 | |
| 343 | 1093070-14-4 | PLpro inhibitor | PLpro inhibitor | C22H22N2O2 | |
| 344 | 1093222-27-5 | Pim1/AKK1-IN-1 | Pim1/AKK1-IN-1 | C20H13N5O | |
| 345 | 1096687-52-3 | SPK-601 | SPK-601 | C11H17KOS2 | |
| 346 | 1099644-42-4 | ITD-1 | ITD-1 | C27H29NO3 | |
| 347 | 1110766-97-6 | Lusutrombopag | Lusutrombopag | C29H32Cl2N2O5S | |
| 348 | 1123231-07-1 | WAY-262611 | WAY-262611 | C20H22N4 | |
| 349 | 1123838-51-6 | Glesatinib (hydrochloride) | Glesatinib (hydrochloride) | C31H28ClF2N5O3S2 | |
| 350 | 1125758-85-1 | A-804598 | A-804598 | C19H17N5 | |
| 351 | 1126084-37-4 | ASP-9521 | ASP-9521 | C19H26N2O3 | |
| 352 | 1132935-63-7 | ABT-333 | ABT-333 | C26H27N3O5S | |
| 353 | 1133432-46-8 | GDC-0834 (Racemate) | GDC-0834 (Racemate) | C33H36N6O3S | |
| 354 | 1137868-52-0 | TAK-960 | TAK-960 | C27H34F3N7O3 | |
| 355 | 1138245-13-2 | Mirogabalin | Mirogabalin | C12H19NO2 | |
| 356 | 115066-14-3 | 6-Cyano-7-Nitroquinoxaline-2,3-Dione | 6-Cyano-7-Nitroquinoxaline-2,3-Dione | C9H4N4O4 | |
| 357 | 1161233-85-7 | BTZ043 | BTZ043 | C17H16F3N3O5S | |
| 358 | 1166827-44-6 | AZD7687 | AZD7687 | C21H25N3O3 | |
| 359 | 116686-15-8 | FK 3311 | FK 3311 | C15H13F2NO4S | |
| 360 | 1170856-93-5 | Calcein (tetraethyl ester) | Calcein (tetraethyl ester) | C38H42N2O13 | |
| 361 | 1181770-72-8 | EMD638683 | EMD638683 | C18H18F2N2O4 | |
| 362 | 1184136-10-4 | UNC-926 Hydrochloride | UNC-926 Hydrochloride | C16H21BrN2O | |
| 363 | 1190932-38-7 | COH29 | COH29 | C22H16N2O5S | |
| 364 | 1191911-26-8 | CZC-25146 | CZC-25146 | C22H25FN6O4S | |
| 365 | 1191911-27-9 | CZC-54252 | CZC-54252 | C22H25ClN6O4S | |
| 366 | 1197300-24-5 | TGR5 Receptor Agonist | TGR5 Receptor Agonist | C18H14Cl2N2O2 | |
| 367 | 1198300-79-6 | Cerdulatinib | Cerdulatinib | C20H27N7O3S | |
| 368 | 1199796-29-6 | INT-777 | INT-777 | C27H46O5 | |
| 369 | 1202916-90-2 | CX-6258 | CX-6258 | C26H24ClN3O3 | |
| 370 | 1206123-37-6 | Etrasimod | Etrasimod | C26H26F3NO3 | |
| 371 | 1206801-37-7 | LY2801653 (dihydrochloride) | LY2801653 (dihydrochloride) | C30H24Cl2F2N6O3 | |
| 372 | 1210004-12-8 | JZL195 | 4-nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate | C24H23N3O5 | |
| 373 | 1211443-80-9 | LEE011 (hydrochloride) | LEE011 (hydrochloride) | C23H31ClN8O | |
| 374 | 1225037-39-7 | PQR309 | PQR309 | C17H20F3N7O2 | |
| 375 | 1229652-21-4 | HA 130 | HA 130 | C24H19BFNO5S | |
| 376 | 123066-64-8 | CRAC intermediate 2 | 4-(3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl)-phenylamine | C11H7F6N3 | |
| 377 | 1232221-74-7 | APY0201 | APY0201 | C23H23N7O | |
| 378 | 1233706-88-1 | CAY10650 | CAY10650 | C28H25NO6 | |
| 379 | 1233948-35-0 | ELR510444 | ELR510444 | C19H16N2O2S2 | |
| 380 | 1234479-76-5 | ERK5-IN-1 | ERK5-IN-1 | C25H29N7O2 | |
| 381 | 1234563-16-6 | Epetraborole (hydrochloride) | Epetraborole (hydrochloride) | C11H16BNO4 | |
| 382 | 1235403-62-9 | PF 05089771 | PF 05089771 | C18H12Cl2FN5O3S2 | |
| 383 | 1235481-90-9 | P7C3-A20 | P7C3-A20 | C22H19Br2FN2O | |
| 384 | 1235560-28-7 | ABT-639 | ABT-639 | C20H20ClF2N3O3S | |
| 385 | 1237744-13-6 | QNZ46 | 4-[6-Methoxy-2-[(1E)-2-(3-nitrophenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl]-benzoic Acid | C24H17N3O6 | |
| 386 | 1252594-99-2 | ETP-46321 | ETP-46321 | C20H27N9O3S | ETP-46321 is a potent and orally bioavailable PI3K α, δ inhibitor with potent biochemical and cellular activity and good pharmacokinetic properties (PK) after oral dosing. ETP-46321 PK/PD studies showed time dependent downregulation of AKT(Ser473) phosphorylation, which correlates with compound levels in tumor tissue and demonstrating to be efficacious in a GEMM mouse tumor model driven by a K-Ras(G12V) oncogenic mutation. Treatment with ETP-46321 resulted in significant tumor growth inhibition. |
| 387 | 1253452-78-6 | KS176 | KS176 | C22H19N3O5 | |
| 388 | 1257213-50-5 | BMS-986020 | BMS-986020 | C29H26N2O5 | |
| 389 | 1257426-19-9 | TBA-354 | TBA-354 | C19H15F3N4O5 | |
| 390 | 1258226-87-7 | Ombitasvir | Ombitasvir | C50H67N7O8 | |
| 391 | 1262618-39-2 | GS967 | GS967 | C14H7F6N3O | |
| 392 | 129198-88-5 | Autocamtide 2 trifluoroacetate salt | Autocamtide 2 trifluoroacetate salt | C65H118N22O20 | |
| 393 | 1292310-49-6 | IKK epsilon-IN-1 | IKK epsilon-IN-1 | C26H27N5O3 | |
| 394 | 1309357-15-0 | CX-4945 (sodium salt) | CX-4945 (sodium salt) | C19H13ClN3NaO2 | |
| 395 | 1309684-94-3 | RO8994 | RO8994 | C31H31Cl2FN4O4 | |
| 396 | 1311367-27-7 | BIX 02565 | BIX 02565 | C26H30N6O2 | |
| 397 | 1313881-70-7 | ARQ-092 | ARQ-092 | C27H24N6 | |
| 398 | 1314118-94-9 | MK2-IN-1 (hydrochloride) | MK2-IN-1 (hydrochloride) | C27H26Cl2N4O2 | |
| 399 | 1314891-22-9 | TMP195 | TMP195 | C23H19F3N4O3 | |
| 400 | 1316755-16-4 | EMA401 | EMA401 | C32H29NO5 | |
| 401 | 132836-42-1 | YS-49 | YS-49 | C20H20BrNO2 | |
| 402 | 1333377-65-3 | CHR-6494 | CHR-6494 | C16H16N6 | |
| 403 | 133413-70-4 | PF 1022A | PF 1022A | C52H76N4O12 | |
| 404 | 1334179-85-9 | {4-[(双{[1-(2-甲基-2-丙基)-1H-1,2,3-三唑-4-基]甲基}氨基)甲基]-1H-1,2,3-三唑 -1-基}乙酸 | (4-{[Bis-(1-tert-butyl-1H-[1,2,3]triazol-4-ylmethyl)-amino]-methyl}-[1,2,3]triazol-1-yl)-acetic acid | C19H30N10O2 | |
| 405 | 1337883-32-5 | DiZPK | DiZPK | C12H23N5O3 | |
| 406 | 1345847-93-9 | Altiratinib | Altiratinib | C26H21F3N4O4 | |
| 407 | 1345982-69-5 | GSK2330672 | GSK2330672 | C28H38N2O7S | |
| 408 | 1350462-55-3 | MK-5172 (hydrate) | MK-5172 (hydrate) | C38H50N6O9S.H2O | |
| 409 | 1350622-33-1 | kb-NB77-78 | kb-NB77-78 | C18H25NO3Si | |
| 410 | 1351522-04-7 | AC710 | AC710 | C31H42N6O4 | |
| 411 | 1352066-68-2 | AMG 232 | AMG 232 | C28H35Cl2NO5S | |
| 412 | 1353625-73-6 | Presatovir | Presatovir | C24H30ClN7O3S | |
| 413 | 1355326-21-4 | Mutant IDH1-IN-1 | Mutant IDH1-IN-1 | C30H31FN4O2 | |
| 414 | 1356962-34-9 | HG-14-10-04 | HG-14-10-04 | C29H34ClN7O | |
| 415 | 1357171-62-0 | ML228 | ML228 | C27H21N5 | |
| 416 | 1357389-11-7 | RGFP966 | RGFP966 | C21H19FN4O | |
| 417 | 1357920-84-3 | Belizatinib | Belizatinib | C33H44FN5O3 | |
| 418 | 1361224-53-4 | AMG-3969 | AMG-3969 | C21H20F6N4O3S | |
| 419 | 1361951-15-6 | TP-3654 | TP-3654 | C22H25F3N4O | |
| 420 | 1365888-06-7 | GDC-0810 | GDC-0810 | C26H20ClFN2O2 | |
| 421 | 1374516-07-0 | TUG-891 | TUG-891 | C23H21FO3 | |
| 422 | 1375465-91-0 | ACY-738 | ACY-738 | C14H14N4O2 | |
| 423 | 1380424-42-9 | KML-29 | KML-29 | C24H21F6NO7 | |
| 424 | 1391712-60-9 | CEP-37440 | CEP-37440 | C30H38ClN7O3 | |
| 425 | 1394854-52-4 | GSK-J2 | GSK-J2 | C22H23N5O2 | |
| 426 | 1401090-53-6 | Ibiglustat | Ibiglustat | C20H24FN3O2S | |
| 427 | 1401242-74-7 | ML277 | ML277 | C23H25N3O4S2 | |
| 428 | 1402821-41-3 | GV-58 | GV-58 | C18H26N6OS | |
| 429 | 1408064-71-0 | JNK-IN-7 | JNK-IN-7 | C28H27N7O2 | |
| 430 | 140926-75-6 | NSC5844 | NSC5844 | C20H16Cl2N4 | |
| 431 | 1418741-86-2 | UNC1079 | UNC1079 | C28H42N4O2 | |
| 432 | 1430213-30-1 | ML216 | ML216 | C15H9F4N5OS | |
| 433 | 1431698-10-0 | OTSSP167 (hydrochloride) | OTSSP167 (hydrochloride) | C25H29Cl3N4O2 | |
| 434 | 1442684-77-6 | AM-2394 | AM-2394 | C22H25N5O4 | |
| 435 | 1445605-23-1 | Lu AF21934 | Lu AF21934 | C14H16Cl2N2O2 | |
| 436 | 1446182-94-0 | CUDC-427 | CUDC-427 | C29H36N6O4S | |
| 437 | 1448895-09-7 | ML314 | ML314 | C24H28N4O3 | |
| 438 | 1449240-68-9 | K145 (hydrochloride) | K145 (hydrochloride) | C18H25ClN2O3S | |
| 439 | 1453097-13-6 | HUHS015 | HUHS015 | C19H18N4O | |
| 440 | 1454619-14-7 | PU-WS13 | PU-WS13 | C17H20Cl2N6S | |
| 441 | 1456858-58-4 | HG-9-91-01 | HG-9-91-01 | C32H37N7O3 | |
| 442 | 146204-42-4 | BM212 | BM212 | C23H25Cl2N3 | |
| 443 | 1462249-75-7 | PFK-158 | PFK-158 | C18H11F3N2O | |
| 444 | 1472624-85-3 | 7ACC2 | 7ACC2 | C18H15NO4 | |
| 445 | 150725-87-4 | Ro 46-2005 | Ro 46-2005 | C23H27N3O6S | |
| 446 | 1516896-09-5 | PDE10-IN-1 | PDE10-IN-1 | C21H19N7 | |
| 447 | 1531634-31-7 | AF38469 | AF38469 | C15H11F3N2O3 | |
| 448 | 1532593-30-8 | ML355 | ML355 | C21H19N3O4S2 | |
| 449 | 1557268-88-8 | Avitinib (maleate) | Avitinib (maleate) | C30H30FN7O6 | |
| 450 | 156223-05-1 | 3-(2,4-dimethoxybenzylidene)anabaseine | 3-(2,4-dimethoxybenzylidene)anabaseine | C19H22Cl2N2O2 | |
| 451 | 156722-18-8 | ROSTAFUROXIN | (3β,5β,14β)-21,23-Epoxy-24-Norchola-20,22-diene-3,14,17-triol | C23H34O4 | |
| 452 | 1599432-08-2 | NIBR189 | NIBR189 | C21H21BrN2O3 | |
| 453 | 1604810-84-5 | THZ2 | THZ2 | C31H28ClN7O2 | |
| 454 | 1621175-65-2 | TC-G-1008 | TC-G-1008 | C18H19ClN6O2S | |
| 455 | 1627696-51-8 | LY3177833 | LY3177833 | C16H12FN5O | |
| 456 | 1628838-42-5 | RAF709 | RAF709 | C28H29F3N4O4 | |
| 457 | 1629869-44-8 | 化合物PIMODIVIR | Pimodivir | C20H19F2N5O2 | Pimodivir, also known as VX-787, JNJ-872, is a novel inhibitor of influenza virus replication that blocks the PB2 cap-snatching activity of the influenza viral polymerase complex. VX-787 binds the cap-binding domain of the PB2 subunit with a KD (dissociation constant) of 24 nM as determined by isothermal titration calorimetry (ITC). The cell-based EC50 (the concentration of compound that ensures 50% cell viability of an uninfected control) for VX-787 is 1.6 nM in a cytopathic effect (CPE) assay, with a similar EC50 in a viral RNA replication assay. VX-787 is active against a diverse panel of influenza A virus strains, including H1N1pdm09 and H5N1 strains, as well as strains with reduced susceptibility to neuraminidase inhibitors (NAIs). |
| 458 | 163769-88-8 | YM-90709 | 5,6-DIHYDRO-2,3-DIMETHOXY-6,6-DIMETHYLBENZ[7,8]INDOLIZINO[2,3-B]QUINOXALINE | C22H21N3O2 | |
| 459 | 1637735-84-2 | FIIN-3 | FIIN-3 | C34H36Cl2N8O4 | |
| 460 | 1640282-31-0 | I-CBP 112 | I-CBP 112 | C27H36N2O5 | |
| 461 | 164178-33-0 | AM 630 | AM 630 | C23H25IN2O3 | |
| 462 | 1642303-38-5 | ITI214 | ITI214 | C29H29FN7O5P | |
| 463 | 164658-13-3 | CGP60474 | CGP60474 | C18H18ClN5O | |
| 464 | 165538-40-9 | Terutroban | Terutroban | C20H22ClNO4S | |
| 465 | 168682-53-9 | Ezatiostat | (S)-ethyl 2-amino-5-(((R)-3-(benzylthio)-1-(((S)-2-ethoxy-2-oxo-1-phenylethyl)amino)-1-oxopropan-2-yl)amino)-5-oxopentanoate | C27H35N3O6S | |
| 466 | 173039-10-6 | 2-PMPA | 2-(Phosphonomethyl)pentanedioic acid | C6H11O7P | |
| 467 | 173529-10-7 | HMN-176 | HMN-176 | C20H18N2O4S | |
| 468 | 173865-33-3 | CDD3505 | CDD3505 | C22H17N3O2 | |
| 469 | 173952-44-8 | SYM2206 | (+/-)-4-(4-AMINOPHENYL)-1,2-DIHYDRO-1-METHYL-2-PROPYLCARBAMOYL-6,7-METHYLENEDIOXYPHTHALAZINE | C20H22N4O3 | |
| 470 | 174634-09-4 | TAS-103 (dihydrochloride) | TAS-103 (dihydrochloride) | C20H21Cl2N3O2 | |
| 471 | 175013-84-0 | Tonabersat | Tonabersat | C20H19ClFNO4 | |
| 472 | 176161-24-3 | BENZIMIDAVIR | BENZIMIDAVIR | C15H19Cl2N3O4 | |
| 473 | 17780-75-5 | N-[3-(2,4-二氯苯氧基)丙基]-N-甲基-2-丙炔胺盐酸盐 | CLORGYLINE HYDROCHLORIDE | C13H16Cl3NO | |
| 474 | 1808011-22-4 | EPZ031686 | EPZ031686 | C26H34ClF3N4O4S | |
| 475 | 1817626-54-2 | PF06650833 | PF06650833 | C18H20FN3O4 | |
| 476 | 1820565-69-2 | PIM-447 (dihydrochloride) | PIM-447 (dihydrochloride) | C24H23F3N4O | |
| 477 | 186953-56-0 | 4,4'-(2,5-呋喃基)双[N-甲氧基苯甲脒] | Pafuramidine | C20H20N4O3 | |
| 478 | 191089-60-8 | K-7174 (dihydrochloride) | K-7174 (dihydrochloride) | C33H48N2O6 | |
| 479 | 193746-75-7 | SB 242235 | SB 242235 | C19H20FN5O | |
| 480 | 195371-52-9 | NSC 42834 | NSC 42834 | C23H24N2O | |
| 481 | 195514-80-8 | AP20187 | AP20187 | C82H107N5O20 | |
| 482 | 195733-43-8 | Atrasentan hydrochloride (ABT-627 hydrochloride) | (2R,3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid hydrochloride | C29H38N2O6.HCl | |
| 483 | 196808-24-9 | GW1929 | GW1929 | C30H29N3O4 | |
| 484 | 199986-75-9 | CVT-313 | CVT-313 | C20H28N6O3 | |
| 485 | 202350-68-3 | PNU-159682 | PNU-159682 | C32H35NO13 | |
| 486 | 204697-65-4 | Olcegepant | Olcegepant | C38H47Br2N9O5 | |
| 487 | 2061980-01-4 | XMU-MP-1 | XMU-MP-1 | C17H16N6O3S2 | |
| 488 | 2076-91-7 | TPT-260 (Dihydrochloride) | TPT-260 (Dihydrochloride) | C8H14Cl2N4S3 | |
| 489 | 210110-90-0 | N-Butyldeoxynojirimycin Hydrochloride | N-Butyldeoxynojirimycin Hydrochloride | C10H22ClNO4 | |
| 490 | 210829-30-4 | Gemcitabine (elaidate) | Gemcitabine (elaidate) | C27H43F2N3O5 | |
| 491 | 212779-48-1 | NG 52 | NG 52 | C16H19ClN6O | |
| 492 | 212844-54-7 | Purvalanol B ( NG 95) | (2R)-2-[[6-[(3-CHLORO-4-CARBOXYPHENYL)AMINO]-9-(1-METHYLETHYL)-9H-PURIN-2-YL]AMINO]-3-METHYL-1-BUTANOL | C20H25ClN6O3 | |
| 493 | 217645-70-0 | BX471 | BX471 | C21H24ClFN4O3 | |
| 494 | 221243-82-9 | 1-Naphthyl PP1 | 4-Amino-1-tert-butyl-3-(1'-naphthyl)pyrazolo[3,4-d]pyrimidine | C19H19N5 | |
| 495 | 224177-60-0 | Siramesine (hydrochloride) | Siramesine (hydrochloride) | C30H32ClFN2O | |
| 496 | 226954-04-7 | Emapunil | AC-5216 | C23H23N5O2 | |
| 497 | 23146-22-7 | IQ-1S (free acid) | IQ-1S (free acid) | C15H9N3O | |
| 498 | 232271-19-1 | TR-14035 | (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid | C24H21Cl2NO5 | |
| 499 | 249537-73-3 | NFAT INHIBITOR | H-MET-ALA-GLY-PRO-HIS-PRO-VAL-ILE-VAL-ILE-THR-GLY-PRO-HIS-GLU-GLU-OH | C75H118N20O22S | |
| 500 | 256477-09-5 | UK-371804 | UK-371804 | C14H16ClN5O4S | |
| 501 | 256925-03-8 | AL 082D06 | AL 082D06 | C23H24ClN3O2 | |
| 502 | 266359-93-7 | Reparixin (L-lysine salt) | Reparixin (L-lysine salt) | C20H35N3O5S | |
| 503 | 271576-80-8 | SD-06 | SD-06 | C20H20ClN5O2 | |
| 504 | 275371-94-3 | Taspoglutide | Taspoglutide | C152H232N40O45 | |
| 505 | 290815-26-8 | Avosentan | Avosentan | C23H21N5O5S | |
| 506 | 306974-70-9 | GW-1100 | GW-1100 | C27H25FN4O4S | |
| 507 | 309271-94-1 | Inauhzin | Inauhzin | C25H19N5OS2 | |
| 508 | 3131-03-1 | Pristinamycin IA | mikamycin B | C45H54N8O10 | |
| 509 | 315694-89-4 | TC-DAPK 6 | TC-DAPK 6 | C17H12N2O2 | |
| 510 | 321688-88-4 | Poloxin | Poloxin | C18H19NO3 | |
| 511 | 329907-28-0 | TTP 22 | TTP 22 | C16H14N2O2S2 | |
| 512 | 330786-25-9 | PCI 29732 | PCI 29732 | C22H21N5O | |
| 513 | 332117-28-9 | Chembridge-5861528 | Chembridge-5861528 | C19H23N5O3 | |
| 514 | 349085-82-1 | GSK137647A | GSK137647A | C16H19NO3S | |
| 515 | 353262-04-1 | NS6180 | NS6180 | C16H12F3NOS | |
| 516 | 354813-19-7 | BALICATIB | Balicatib | C23H33N5O2 | |
| 517 | 36341-25-0 | YL-109 | 2-(4-HYDROXY-3-METHOXYPHENYL)BENZOTHIAZOLE | C14H11NO2S | |
| 518 | 370586-05-3 | CID-797718 | CID-797718 | C12H11NO3 | |
| 519 | 377727-87-2 | Preladenant | Preladenant | C25H29N9O3 | |
| 520 | 40013-87-4 | 24, 25-Dihydroxy VD3 | 24, 25-Dihydroxy VD3 | C27H44O3 | |
| 521 | 406205-74-1 | Bay 59-3074 | Bay 59-3074 | C18H13F6NO4S | |
| 522 | 406209-26-5 | ACHP (Hydrochloride ) | ACHP (Hydrochloride ) | C21H25ClN4O2 | |
| 523 | 41332-24-5 | NP118809 | NP118809 | C32H32N2O | |
| 524 | 415713-60-9 | RI-1 | RI-1 | C14H11Cl3N2O3 | |
| 525 | 432001-69-9 | Skp2 Inhibitor C1 | Skp2 Inhibitor C1 | C18H13BrN2O4S2 | |
| 526 | 439083-90-6 | Bay 60-7550 | Bay 60-7550 | C27H32N4O4 | |
| 527 | 439288-66-1 | GW627368 | GW627368 | C30H28N2O6S | |
| 528 | 448906-42-1 | ITE | methyl 2-(1H-indole-3-carbonyl)thiazole-4-carboxylate | C14H10N2O3S | |
| 529 | 448947-81-7 | GlyT2-IN-1 | GlyT2-IN-1 | C13H8Cl2N4S2 | |
| 530 | 454453-49-7 | kobe2602 | 2-[2,6-Dinitro-4-(trifluoromethyl)phenyl]-N-(4-fluorophenyl)hydrazinecarbothioamide | C14H9F4N5O4S | |
| 531 | 457081-03-7 | Pyridone 6 | Pyridone 6 | C18H16FN3O | |
| 532 | 477908-53-5 | CY7-SE | 2-((1E,3E,5E)-7-((E)-1-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-3,3-dimethyl-5-sulfoindolin-2-ylidene)hepta-1,3,5-trien-1-yl)-1-ethyl-3,3-dimethyl-3H-indol-1-ium-5-sulfonate | C39H45N3O10S2 | |
| 533 | 483313-22-0 | SB-674042 | SB-674042 | C24H21FN4O2S | |
| 534 | 486427-17-2 | CIQ | CIQ | C26H26ClNO5 | |
| 535 | 491871-58-0 | TCS PIM-1 1 | TCS PIM-1 1 | C18H11BrN2O2 | |
| 536 | 496791-37-8 | AR-C155858 | AR-C155858 | C21H27N5O5S | |
| 537 | 496794-70-8 | N-[4-氯-3-[5-(二甲基氨基)-1H-苯并咪唑-2-基]苯基]-3,5-二甲氧基苯甲酰胺 | HhAntag | C24H23ClN4O3 | |
| 538 | 516480-79-8 | BML-277 | BML-277 | C20H14ClN3O2 | |
| 539 | 518058-84-9 | KX1-004 | KX1-004 | C16H13FN2O2 | |
| 540 | 529488-28-6 | Genz-644282 | 2,3-dimethoxy-12-(2-(methylamino)ethyl)-[1,3]dioxolo[4',5':4,5]benzo[1,2-h]benzo[c][1,6]naphthyridin-13(12H)-one | C22H21N3O5 | |
| 541 | 530141-72-1 | T-5224 | T-5224 | C29H27NO8 | |
| 542 | 537034-17-6 | CAY10433 | BML-210 | C20H25N3O2 | |
| 543 | 5465-86-1 | 4-Methyl-2-(1-piperidinyl)-quinoline | 4-Methyl-2-(1-piperidinyl)-quinoline | C15H18N2 | |
| 544 | 547757-23-3 | BMS-345541 HCl | BMS-345541 hydrochloride | C14Cl1H18N5 | BMS-345541 hydrochloride 是一种选择性的 IKK 催化亚基 IKK-1 和 IKK-2 抑制剂，抑制 IKK-2 和 IKK-1，IC50 值分别为 0.3 μM 和 4 μM。BMS-345541 与 IKK 的变构位点结合。 |
| 545 | 54-91-1 | Pipobroman | Pipobroman | C10H16Br2N2O2 | |
| 546 | 56396-35-1 | 2-氰基-3-(1-苯基-1H-吲哚-3-基)-2-丙烯酸 | 2-cyano-3-(1-phenylindol-3-yl)acrylate | C18H12N2O2 | |
| 547 | 587850-67-7 | 4-Amino-N-phenethylbenzenesulfonamide | 4-Amino-N-phenethylbenzenesulfonamide | C14H16N2O2S | |
| 548 | 591778-70-0 | CP-640186 (hydrochloride) | CP-640186 (hydrochloride) | C30H36ClN3O3 | |
| 549 | 603148-36-3 | Azeliragon (TTP488) | 1-PropanaMine, 3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-iMidazol-4-yl]phenoxy]-N,N-diethyl- | C32H38ClN3O2 | |
| 550 | 606101-58-0 | MK-0773 | MK-0773 | C27H34FN5O2 | |
| 551 | 613677-28-4 | Lasmiditan (hydrochloride) | Lasmiditan (hydrochloride) | C19H19ClF3N3O2 | |
| 552 | 627908-92-3 | SU14813 | SU14813 | C23H27FN4O4 | |
| 553 | 630124-46-8 | AST 487 | AST 487 | C26H30F3N7O2 | |
| 554 | 638156-11-3 | CID 2011756 | 5-(3-Chlorophenyl)-N-[4-morpholin-4-ymethyl)phenyl]furan-2-carboxamide | C22H21ClN2O3 | |
| 555 | 64048-12-0 | 2,3,4,5-Tetra-(4-Pyridyl) Thiophene | 2,3,4,5-Tetra-(4-Pyridyl) Thiophene | C24H16N4S | |
| 556 | 660868-91-7 | GW843682X | GW843682X | C22H18F3N3O4S | |
| 557 | 664993-53-7 | JW-55 | JW-55 | C25H26N2O5 | |
| 558 | 67469-81-2 | GBR 12935 dihydrochloride | 1-(2-DIPHENYLMETHOXYETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE DIHYDROCHLORIDE | C28H36Cl2N2O | |
| 559 | 681159-27-3 | CBR-5884 | CBR-5884 | C14H12N2O4S2 | |
| 560 | 681492-22-8 | (2R)-2,3-二氢-2-甲基-6-硝基-2-[[4-[4-[4-(三氟甲氧基)苯氧基]-1-哌啶基]苯氧基]甲基]咪唑并[2,1-B]恶唑 | Delamanid | C25H25F3N4O6 | |
| 561 | 690270-29-2 | Balapiravir | Balapiravir | C21H30N6O8 | |
| 562 | 697235-38-4 | Silvestrol | Silvestrol | C34H38O13 | |
| 563 | 71418-44-5 | 荧光专用试剂 | mBBr [Monobromobimane] | C10H11BrN2O2 | |
| 564 | 72873-74-6 | SKF-86002 | 6-(4-FLUOROPHENYL)-2,3-DIHYDRO-5-(4-PYRIDINYL)IMIDAZO[2,1-B]THIAZOLE DIHYDROCHLORIDE | C16H12FN3S | |
| 565 | 72926-24-0 | K858 | N-(4-Acetyl-4,5-dihydro-5-methyl-5-phenyl-1,3,4-thiadiazol-2-yl)acetamide | C13H15N3O2S | |
| 566 | 73043-80-8 | 1-Methyl-7-nitroisatoic anhydride | 1-Methyl-7-nitroisatoic anhydride | C9H6N2O5 | |
| 567 | 752187-80-7 | Taprenepag | Taprenepag | C24H22N4O5S | |
| 568 | 758679-97-9 | CID-2858522 | CID-2858522 | C28H39N3O3 | |
| 569 | 761436-81-1 | ALK inhibitor 1 | 2-[[5-Bromo-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]-N-methylbenzenesulfonamide | C23H28BrN7O3S | |
| 570 | 774549-97-2 | KM11060 | KM11060 | C19H17Cl2N3O2S | |
| 571 | 783348-36-7 | MLN120B | MLN120B | C19H15ClN4O2 | |
| 572 | 785835-79-2 | JDTic (dihydrochloride) | JDTic (dihydrochloride) | C28H40ClN3O3 | |
| 573 | 79756-69-7 | TPI-1 | TPI-1 | C12H6Cl2O2 | |
| 574 | 80306-38-3 | AR7 | AR7 | C15H12ClNO | |
| 575 | 834903-43-4 | CID 16020046 | CID 16020046 | C25H19N3O4 | |
| 576 | 845533-86-0 | Bedaquiline (fumarate) | Bedaquiline (fumarate) | C36H35BrN2O6 | |
| 577 | 845614-11-1 | Bitopertin | Bitopertin | C21H20F7N3O4S | |
| 578 | 84783-01-7 | K-Ras-IN-1 | K-Ras-IN-1 | C11H13NOS | |
| 579 | 848193-68-0 | EX-527(S-enantiomer) | EX527 | C13H13ClN2O | |
| 580 | 848344-36-5 | Bentamapimod ( AS 602801) | 2-(1,3-benzothiazol-2-yl)-2-[2-({4-[(morpholin-4-yl)methyl]phenyl}methoxy)pyrimidin-4-yl]acetonitrile | C25H23N5O2S | |
| 581 | 848354-66-5 | NCH-51 | PTACH | C20H26N2O2S2 | |
| 582 | 849550-05-6 | Cevipabulin (TTI-237) | 5-Chloro-6-[2,6-difluoro-4-[3-(methylamino)propoxy]phenyl]-N-((1S)-2,2,2-trifluoro-1-methylethyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine | C18H18ClF5N6O | |
| 583 | 85081-18-1 | NBI-98782((+)-α-Dihydrotetrabenazine) | [2R-(2a,3b,11bb)]-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol | C19H29NO3 | |
| 584 | 85650-57-3 | Setiptiline (maleate) | Setiptiline (maleate) | C23H23NO4 | |
| 585 | 857066-90-1 | TMC353121 | TMC353121 | C32H42N6O3 | |
| 586 | 863774-58-7 | Dimethylenastron | Dimethylenastron | C16H18N2O2S | |
| 587 | 865305-30-2 | AF-353 ( Ro-4) | 2,4-PyriMidinediaMine, 5-[5-iodo-4-Methoxy-2-(1-Methylethyl)phenoxy]- | C14H17IN4O2 | |
| 588 | 865783-99-9 | Briciclib | Phenol, 2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]-, 1-(dihydrogen phosphate) | C19H23O10PS | |
| 589 | 870843-42-8 | E 2012 | (E)-1-[(1S)-1-(4-Fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylidene]piperidin-2-one | C25H26FN3O2 | |
| 590 | 871543-07-6 | H1152 Dihydrochloride | H-1152 Dihydrochloride | C16H21N3O2S | |
| 591 | 873305-35-2 | AIM-100 | AIM-100 | C23H21N3O2 | |
| 592 | 878419-78-4 | Walrycin B | Walrycin B | C14H10F3N5O2 | |
| 593 | 880549-30-4 | AMD-070 (hydrochloride) | AMD-070 (hydrochloride) | C21H28ClN5 | |
| 594 | 882531-87-5 | R1530 | R1530 | C18H14ClFN4O | |
| 595 | 882663-88-9 | AMG-47a | AMG-47a | C29H28F3N5O2 | |
| 596 | 891494-64-7 | SCH900776 (S-isomer) | SCH900776 (S-isomer) | C15H18BrN7 | |
| 597 | 892549-43-8 | MF63 | MF63 | C23H11ClN4 | |
| 598 | 894002-50-7 | 化合物LDN-212320 | LDN-212320 | C17H15N3S | |
| 599 | 894787-30-5 | ST 2825 | ST 2825 | C27H28Cl2N4O5S | |
| 600 | 897657-95-3 | MSX-122 | MSX-122 | C16H16N6 | |
| 601 | 903576-44-3 | Pitolisant hydrochloride | 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride | C17H26ClNO.HCl | |
| 602 | 914295-16-2 | Fostamatinib Disodium Hexahydrate | Fostamatinib Disodium Hexahydrate | C23H24FN6Na2O9P | |
| 603 | 916141-36-1 | TCS 1102 | N-[1,1'-Biphenyl]-2-yl-1-[2-[(1-methyl-1H-benzimidazol-2-yl)thio]acetyl-2-pyrrolidinedicarboxamide | C27H26N4O2S | |
| 604 | 916170-19-9 | AC-55541 | (2E)-2-[1-(3-Bromophenyl)ethylidene]α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineaceticacidhydrazide | C25H20BrN5O3 | |
| 605 | 919351-41-0 | AZD1283 | AZD1283 | C23H26N4O5S | |
| 606 | 919486-40-1 | AS1517499 | 5-PyriMidinecarboxaMide, 2-[[2-(3-chloro-4-hydroxyphenyl)ethyl]aMino]-4-[(phenylMethyl)aMino]- | C20H20ClN5O2 | |
| 607 | 923262-96-8 | SAR407899 (hydrochloride) | SAR407899 (hydrochloride) | C14H17ClN2O2 | SAR407899 is a potent and selective Rho kinase inhibitor with promising antihypertensive activity. SAR407899 potently inhibits endothelin-1-induced constriction of renal resistance arteries. SAR407899 is equipotent against human and rat-derived Rho-kinase 2 with inhibition constant values of 36 nM and 41 nM, respectively. SAR407899 is approximately 8-fold more active than fasudil. SAR407899 potently (mean IC(50) values: 122 to 280 nM) and species-independently relaxed precontracted isolated arteries of different species and different vascular beds. The antihypertensive effect of SAR407899 was superior to that of fasudil and Y-27632. |
| 608 | 929007-72-7 | DB07268 | DB07268 | C17H15N5O2 | |
| 609 | 931706-15-9 | PPQ-102 | PPQ-102 | C26H22N4O3 | |
| 610 | 935467-97-3 | TH 237A | TH 237A | C18H17F2NO3 | |
| 611 | 940908-79-2 | R-7128 | R-7128 | C18H26FN3O6 | Mericitabine is a nucleoside HCV NS5B polymerase inhibitor. It acts as an RNA chain terminator and prevents the elongation of RNA transcripts during replication. |
| 612 | 943962-47-8 | BMS-303141 | BMS-303141 | C19H15Cl2NO4S | |
| 613 | 946387-07-1 | RN-1734 | 2,4-dichloro-N-isopropyl-N-[2-(isopropylamino)ethyl]benzenesulfonamide | C14H22Cl2N2O2S | |
| 614 | 947914-18-3 | ML365 | ML365 | C22H20N2O3 | |
| 615 | 950912-80-8 | PF-670462 | PF-670462 | C19H20FN5.2HCl | |
| 616 | 95167-41-2 | DY131 | DY131 | C18H21N3O2 | |
| 617 | 957118-49-9 | MK-3207 | MK-3207 | C31H29F2N5O3 | |
| 618 | 957135-43-2 | SM-164 | SM-164 | C62H84N14O6 | |
| 619 | 610318-54-2 | RGX-104 free Acid | RGX-104 free Acid | C34H33ClF3NO3 | |
| 620 | 1009734-33-1 | 5-tert-butoxyquinazoline-2,4-diaMine | 5-tert-butoxyquinazoline-2,4-diaMine | C12H16N4O | |
| 621 | 174262-13-6 | SDZ285-428 | SDZ285-428 | C24H20ClN3O | |
| 622 | 197250-15-0 | GAP26 | GAP 26 | C70H107N19O19S | |
| 623 | 1922153-17-0 | MELK-8a | MELK-8a | C25H32N6O | |
| 624 | 1450881-55-6 | SAR-20347 | SAR-20347 | C21H18ClFN4O4 | |
| 625 | 23555-00-2 | Hoechst 34580 | Hoechst 34580 | C27H29N7 | |
| 626 | 1026680-07-8 | LB-100 | LB-100 | C13H20N2O4 | |
| 627 | 1047634-63-8 | GSK2110183 | GSK2110183 | C18H16Cl2F2N4OS | |
| 628 | 1070773-09-9 | RK-33 | RK-33 | C23H20N6O3 | |
| 629 | 1187990-87-9 | MK-8617 | MK-8617 | C24H21N5O4 | |
| 630 | 1223397-11-2 | WZB117 | WZB-117 | C20H13FO6 | |
| 631 | 1226895-15-3 | FLLL32 | FLLL-32 | C28H32O6 | |
| 632 | 1256493-34-1 | Dyngo-4a | Dyngo-4a | C18H14N2O5 | |
| 633 | 152095-12-0 | Dp44mT | Dp44mT | C14H15N5S | |
| 634 | 185039-89-8 | PD0166285 | PD0166285 | C26H27Cl2N5O2 | |
| 635 | 440662-09-9 | CeMMEC1 HCl | CeMMEC1 HCl | C19H16N2O4 | |
| 636 | 459836-30-7 | PEAQX | PEAQX | C17H17BrN3O5P | |
| 637 | 623152-17-0 | BMS-582949 | BMS-582949 | C22H26N6O2 | |
| 638 | 878141-96-9 | S1RA | S1RA | C20H23N3O2 | |
| 639 | 947303-87-9 | PF 429242 | 4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinylbenzamide | C25H35N3O2 | |
| 640 | 591778-68-6 | CP-640186 | CP-640186 | C30H35N3O3 | |
| 641 | 1005334-57-5 | CVT-10216 | CVT-10216 | C24H19NO7S | |
| 642 | 102961-72-8 | Dalbavancin IMpurity - A40926 | Dalbavancin IMpurity - A40926 | C83H86Cl2N8O30 | |
| 643 | 1111556-37-6 | Takinib | Takinib | C18H18N4O2 | |
| 644 | 1204669-37-3 | IDO inhibitor 1 | IDO inhibitor 1 | C11H13BrFN7O4S | |
| 645 | 1216665-49-4 | APY29 | APY29 | C17H16N8 | |
| 646 | 1235481-43-2 | P7C3-Ome | (R)-1-(3,6-dibroMo-9H-carbazol-9-yl)-3-(3-MethoxyphenylaMino)propan-2-ol | C22H20Br2N2O2 | |
| 647 | 1261289-04-6 | O-304 | O-304 | C16H11Cl2N3O2S | |
| 648 | 1342276-76-9 | RKI-1313 | 1-(3-Methoxybenzyl)-3-(4-(pyridin-4-yl)thiazol-2-yl)urea | C17H16N4O2S | |
| 649 | 1345675-25-3 | E-6446二氢氯化物 | E6446 (dihydrochloride) | C27H36ClN3O3 | |
| 650 | 1513879-19-0 | KDU691 | KDU691 | C22H18ClN5O2 | |
| 651 | 1542135-76-1 | LML134 | LML-134 | C19H29N5O3 | |
| 652 | 1802326-66-4 | JNJ 63533054 | JNJ 63533054 | C17H17ClN2O2 | |
| 653 | 1811510-56-1 | PF-6260933 | PF-6260933 | C16H13ClN4 | |
| 654 | 21561-09-1 | WHI-P258 | 4-PHENYLAMINO-6,7-DIMETHOXYQUINAZOLINE | C16H15N3O2 | |
| 655 | 832714-46-2 | APD668 | ISOPROPYL 4-(1-(2-FLUORO-4-(METHYLSULFONYL)PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLOXY)PIPERIDINE-1-CARBOXYLATE | C21H24FN5O5S | |
| 656 | 1094042-01-9 | CYM5442 | 2-(4-(5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanolhydrochloride | C23H27N3O4 | |
| 657 | 926037-48-1 | Radotinib(IY-5511) | Radotinib(IY-5511) | C27H21F3N8O | |
| 658 | 64862-96-0 | Ametantrone | Ametantrone | C22H28N4O4 | |
| 659 | 442908-10-3 | Vipadenant (BIIB 014) | Vipadenant(BIIB-014; CEB-4520) | C16H15N7O | |
| 660 | 1033805-22-9 | Telotristat ethyl | LX1606 | C27H26ClF3N6O3 | |
| 661 | 389139-89-3 | 奥玛环素 | Amadacycline | C29H40N4O7 | |
| 662 | 371924-24-2 | MCU-i4 | MCU-i4 | C23H27N3O2 | Description: MCU-i4 is a novel negative modulator of the MCU, binding MICU1 and impairing muscle cell growth. |
| 663 | 88235-25-0 | C-6 NBD | C-6 NBD | C12H14N4O5 | C-6 NBD is a derivative of the environmentally-sensitive fluorophore nitrobenzoxadiazole (NBD; absorbance 465 nm, emission 535 nm). It is modified with a hexanoic acid tail, which provides a reactive carboxylic acid site. C-6 NBD has been used to synthesize a variety of fluorescently-tagged compounds for research purposes. |
| 664 | 1231929-97-7 | 阿贝西利 | Abemaciclib | C27H32F2N8 | |
| 665 | 1261114-01-5 | GNF179 | GNF179 | C22H23ClFN5O | |
| 666 | 1568-80-5 | 3,3,3',3'-四甲基-1,1'-螺BI(茚满)-6,6'-二醇 | SPIROBIINDANE | C21H24O2 | |
| 667 | 176644-21-6 | N-(二氨基亚甲基)-2-甲基-5-(甲基磺酰基)-4-(1H-吡咯-1-基)苯甲酰胺 | ENIPORIDE | C14H16N4O3S | |
| 668 | 212201-70-2 | Ipfencarbazone | Ipfencarbazone | C18H14Cl2F2N4O2 | |
| 669 | 36536-22-8 | 1,1',3,3,3',3'-六甲基吲哚双碳菁碘 | 1,1',3,3,3',3'-HEXAMETHYLINDODICARBOCYANINE IODIDE | C27H31IN2 | |
| 670 | 1516895-53-6 | SEP-0372814 | SEP-0372814 | C21H19N7 | |
| 671 | 1197196-48-7 | UNC0224 | UNC0224 | C26H43N7O2 | |
| 672 | 1247825-37-1 | 4-氰基-5-[(3,5-二氯-4-吡啶基)硫基]-N-[4-(甲基磺酰基)苯基]-2-噻吩甲酰胺 | 2-ThiophenecarboxaMide, 4-cyano-5-[(3,5-dichloro-4-pyridinyl)thio]-N-[4-(Methylsulfonyl)phenyl]- | C18H11Cl2N3O3S3 | |
| 673 | 125314-64-9 | Ro 31-8220 | Ro 31-8220 | C25H23N5O2S | |
| 674 | 592542-59-1 | (2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT | (2-METHOXY-5-[2-(2,4,6-TRIMETHOXY-PHENYL)-ETHENESULFONYLMETHYL]-PHENYLAMINO)-ACETIC ACID, SODIUM SALT | C21H25NO8S | |
| 675 | 93129-94-3 | Tacalcitol Monohydrate | Tacalcitol Monohydrate | C27H44O3 | |
| 676 | 501010-06-6 | GGTI-2418 | GGTI-2418 | C23H31N5O4 | |
| 677 | 1380087-89-7 | CPI-0610 | CPI-0610 | C20H16ClN3O2 | |
| 678 | 1037592-40-7 | CS-2494 | JPH203 | C23H19Cl2N3O4 | |
| 679 | 47623-98-3 | 双(1,3-二乙基硫代巴比妥酸)三次甲基氧杂菁 | BIS-(1,3-DIETHYLTHIOBARBITURIC ACID)TRIMETHINE OXONOL | C19H24N4O4S2 | |
| 680 | 127274-91-3 | 1,1'-双十八烷基-3,3,3',3'-四甲基吲哚二碳菁高氯酸盐 | 1,1'-DIOCTADECYL-3,3,3',3'-TETRAMETHYLINDODICARBOCYANINE PERCHLORATE | C61H99ClN2O4 | |
| 681 | 136164-66-4 | E3330 | (E)-2-((4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylene)undecanoic acid | C21H30O6 | |
| 682 | 909115-33-9 | (GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯 | FMOC-GLU(OTBU)-SER(PSI-ME,MEPRO)-OH | C30H36N2O8 | |
| 683 | 170006-73-2 | FTI-277 | FTI-277 | C22H29N3O3S2 | |
| 684 | 1422144-42-0 | 奈他地尔 二甲磺酸盐 | AR-13324 (mesylate) | C30H35N3O9S2 | |
| 685 | 131875-08-6 | Lexacalcitol | Lexacalcitol | C29 H48 O4 | |
| 686 | 1313498-08-6 | LSN2814617消旋体 | LSN2814617 | C18H20FN5O | |
| 687 | 1391426-22-4 | N2-(7-Chloro-4-quinolinyl)-N1-[2-[(7-chloro-4-quinolinyl)amino]ethyl]-N1-methyl-1,2-ethanediamine | N2-(7-Chloro-4-quinolinyl)-N1-[2-[(7-chloro-4-quinolinyl)amino]ethyl]-N1-methyl-1,2-ethanediamine | C23H23Cl2N5 | |
| 688 | 1304630-27-0 | NGP 555 | NGP 555 | C23H23FN4S | |
| 689 | 1038915-64-8 | 甲苯磺酸尼拉帕利 | (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide | C19H20N4O | |
| 690 | 96736-11-7 | 链丝菌素硫酸盐 | NOURSEOTHRICIN SULFATE | C44H82N18O21S | |
| 691 | 1401031-39-7 | TRV-130 | TRV-130 | C22H31ClN2O2S | |
| 692 | 16201-96-0 | 4-苯氮霉素 | 4-Phenylazomaleinanil | C16H11N3O2 | |
| 693 | 171436-38-7 | SER-LEU-ILE-GLY-ARG-LEU-NH2 | H-SER-LEU-ILE-GLY-ARG-LEU-NH2 | C29H56N10O7 | |
| 694 | 1234708-04-3 | N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide | N-(3-(5-(2-hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyriMidine-5-carboxaMide | C22H20N6O3 | |
| 695 | 36099-95-3 | H-TRP-GLU-OH | H-TRP-GLU-OH | C16H19N3O5 | |
| 696 | 161582-11-2 | RO 48-8071盐 | (4-BROMOPHENYL)[3-FLUORO-4-[[6-(METHYL-2-PROPENYLAMINO)HEXYL]OXY]PHENYL]-METHANONE | C23H27BrFNO2 | |
| 697 | 1781835-13-9 | RN1; RN 1 | RN-1 (hydrochloride) | C23H31Cl2N3O2 | |
| 698 | 151823-14-2 | N-[1-[(2R,3S,4S,5R)-3-氰基-4-羟基-5-(羟甲基)氧杂环戊-2-基]-2-氧代嘧啶-4-基]十六酰胺 | Sapacitabine | C26H42N4O5 | |
| 699 | 115104-28-4 | MK-571钠盐 | (E)-3-[[[3-[2-(7-CHLORO-2-QUINOLINYL)ETHENYL]PHENYL]-[[(3-DIMETHYLAMINO)-3-OXOPROPYL]THIO]METHYL]THIO]-PROPANOIC ACID, SODIUM SALT | C26H27ClN2O3S2 | |
| 700 | 106635-80-7 | TAFENOQUINE | Tafenoquine | C24H28F3N3O3 | |
| 701 | 1354825-58-3 | N-[2-[4-氨基-3-(4-甲基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基]-2-甲基丙基]-4-吡啶甲酰胺 | WEHI-345 | C22H23N7O | |
| 702 | 78123-71-4 | (D-ALA2,N-ME-PHE4,GLYCINOL5)-ENKEPHALIN | DAGO | C26H35N5O6 | |
| 703 | 265129-71-3 | 2-[[4-[2-[[环己基氨基)羰基](4-环己基丁基)氨基]乙基]苯基]硫基]-2-甲基丙酸 | GW7647 | C29H46N2O3S | |
| 704 | 871266-63-6 | PCI-27483 | PCI-27483 | C26H24N6O9S | |
| 705 | 80724-19-2 | 5-TRITC; G isomer [Tetramethylrhodamine-5-isothiocyanate] | 5-TRITC; G isomer [Tetramethylrhodamine-5-isothiocyanate] | C25H21N3O3S | Amine-Reactive Fluorescent probe for conjugation to peptides or proteins |
| 706 | 98569-12-1 | 2-叔丁氧羰酰胺-1,2,3,4-四氢萘-2-羧酸 | 2-(Tert-Butoxycarbonylamino)-1,2,3,4-Tetrahydronaphthalene-2-Carboxylic Acid | C16H21NO4 | |
| 707 | 100068-60-8 | 1,1'-二十八烷基-3,3,3',3'-碘化四甲基吲哚核花青 | DiR' [DiIC18(7)] | C63H101IN2 | |
| 708 | 1028969-49-4 | MCOPPB TRIHYDROCHLORIDE | 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-(3R)-3-piperidinyl-1H-benzimidazoletrihydrochloride | C26H40N4 | |
| 709 | 1211877-36-9 | N-[(苯基甲氧基)羰基]-L-亮氨酰-N-[(1S)-1-甲酰基-3-甲基丁基]-D-亮氨酰胺 | (R)-MG132 | C26H41N3O5 | |
| 710 | 1346133-08-1 | LY2795050 | LY2795050 | C23H22ClN3O2 | |
| 711 | 15790-91-7 | (Z)-2-decenoic acid | (Z)-2-decenoic acid | C10H18O2 | |
| 712 | 204697-37-0 | 5'-荧光素氨基磷酸酯 | 5'(6)-FAM | C46H58N3O10P | |
| 713 | 21438-60-8 | His-Ser | His-Ser | C9H14N4O4 | |
| 714 | 223132-37-4 | 5-[[4-[[6-(4-氨基-3,5-二甲基苯氧基)-1-甲基-1H-苯并咪唑-2-基]甲氧基]苯基]甲基]-2,4-噻唑啉二酮 | inolitazone | C27H26N4O4S | |
| 715 | 34994-50-8 | 试卤灵钠盐 | Resorufin Sodium Salt | C12H6NNaO3 | |
| 716 | 376594-67-1 | LY450108 | LY450108 | C19H22F2N2O3S | |
| 717 | 38880-58-9 | (2-羟乙基)二甲基(3-磺丙基)氢氧化铵内酯 [用于生化研究] | (2-Hydroxyethyl)dimethyl(3-sulfopropyl)ammonium Hydroxide Inner Salt [for Biochemical Research] | C7H19NO5S | |
| 718 | 50299-12-2 | H-THR-LEU-OH | H-THR-LEU-OH | C10H20N2O4 | |
| 719 | 558447-26-0 | AMD-070 | (S)-N1-((1H-benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine | C21H27N5 | |
| 720 | 722543-31-9 | AZD1152 | AZD1152 | C26H31FN7O6P | |
| 721 | 897383-62-9 | AST-1306 | AST-1306 | C24H18ClFN4O2 | |
| 722 | 942142-51-0 | VTP 27999 | VTP 27999 | C26H41ClN4O5 | |
| 723 | 943134-39-2 | GAP-134 | GAP-134 | C14H17N3O4 | |
| 724 | 6403-16-3 | Ser-Glu | Ser-Glu | C8H14N2O6 | |
| 725 | 115532-50-8 | TMRM [Tetramethylrhodamine, methyl ester, perchlorate] | TMRM [Tetramethylrhodamine, methyl ester, perchlorate] | C25H25ClN2O7 | |
| 726 | 62004-35-7 | LFM-A13 | LFM-A13 | C11H8Br2N2O2 | |
| 727 | 286456-42-6 | L-838417 | L-838417 | C19H19F2N7O | |
| 728 | 165800-04-4 | Eperezolid | (S)-N-((3-(3-Fluoro-4-(4-(2-hydroxyacetyl)piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide | C18H23FN4O5 | |
| 729 | 115532-52-0 | TMRE [Tetramethylrhodamine, ethyl ester, perchlorate] | TMRE [Tetramethylrhodamine, ethyl ester, perchlorate] | C26H27ClN2O7 | |
| 730 | 127500-84-9 | CS-2324 | RO 41-1049 HCL MAO-A INHIBITOR | C12H12FN3OS | |
| 731 | 1239262-52-2 | Tubastatin A Trifluoroacetic Acid Salt | Tubastatin A Trifluoroacetic Acid Salt | C22H22F3N3O4 | |
| 732 | 1254036-77-5 | GSK2269557 | GSK-2269557 | C26H29ClN6O | |
| 733 | 1063331-94-1 | N-(4-氯苯基)-2-(3,5-二甲基-1H-吡唑-1-基)-9-甲基-9H-嘌呤-6-胺 | N-(4-chlorophenyl)-2-(3,5-diMethyl-1H-pyrazol-1-yl)-9-Methyl-9H-purin-6-aMine | C17H16ClN7 | |
| 734 | 210473-10-2 | N-[芴甲氧羰基]-D-蛋氨酸五氟苯基酯 | FMOC-D-MET-OPFP | C26H20F5NO4S | |
| 735 | | SP-琼脂糖凝胶FF | SP SEPHAROSE | | 具有高化学稳定性、高流速、高载量、好的机械性能、可在位清洗、多次重复使用等特点，非特异性吸附低，回收率高，适用于工业规模生产，适用于在pH工作范围内可形成正离子的生物大分子的分离纯化，广泛用于生物制药和生物工程下游蛋白质、核酸及多肽的离子交换制备。 |
| 736 | 869062-42-0 | 鼠李糖脂 | rhamnolipid | | |
| 737 | 15769-56-9 | L-古罗糖醛酸单糖 | guluronic acid | C6H10O7 | Guluronic acid (G2013) 是透明质酸的有机组成部分之一，是一种非甾体抗炎药，具有良好的抗炎作用。 |
| 738 | | 弗氏不完全佐剂 | Freund 's Adjuvant Incomplete | | |
| 739 | 60842-46-8 | 荧光素异硫氰酸酯-葡聚糖 | FLUORESCEIN ISOTHIOCYANATE-DEXTRAN | | |
| 740 | 387334-31-8 | 2-(叔丁氧基羰基)-2-甲基-3,4-二氢-2H-吡咯 1-氧化物 | BMPO | C10H17NO3 | |
| 741 | | FMOC-LYS(BOC)-WANG RESIN | FMOC-LYS(BOC)-WANG RESIN | C26H31N2O5R | |
| 742 | | 苏木素染色液 | Hematoxylin staining solution | | |
| 743 | 1177827-73-4 | AP-III-a4(ENOblock) | AP-III-a4(ENOblock) | C31H43FN8O3 | ENOblock(AP-III-a4)是第一个非底物类似物，可直接与烯醇酶结合，IC50为0.576 uM，能抑制体内癌细胞转移。 |
| 744 | 301836-43-1 | D4476 | D4476 | C23H18N4O3 | |
| 745 | 32343-73-0 | N-(5-氨基戊基)乙酰胺 | N-(5-Aminopentyl)acetamide | C7H16N2O | |
| 746 | 1137916-97-2 | MK-0941 | MK0941 | C22H28N4O9S2 | |
| 747 | 911714-45-9 | SP-420 | SP-420 | C16H21NO6S | SP-420是desferrithiocin类似物，比desferrithiocin的铁清除效率更高，ICE值26.7。 |
| 748 | 71977-09-8 | Substance P, Free Acid | Substance P, Free Acid | C63H97N17O14S | |
| 749 | 497833-27-9 | Givinostat | Givinostat | C24H27N3O4 | Givinostat (ITF-2357) 是 HDAC 抑制剂。抑制 HDAC1 和 HDAC3，IC50 分别为 198 nM 和 157 nM。 |
| 750 | 223652-90-2 | Garenoxacin Mesylate hydrate | Garenoxacin Mesylate hydrate | C23H20F2N2O4.CH4O3S.H2O | |
| 751 | 229305-39-9 | Golotimod (SCV-07) | Golotimod (SCV-07) | C16H19N3O5 | |
| 752 | 56715-13-0 | (R)-(+)-Atenolol | (R)-(+)-Atenolol | C14H22N2O3 | |
| 753 | 1032678-07-1 | Cy5 羧酸 | Cy5 carboxylic acid | C32H39ClN2O2 | |
| 754 | 1000873-98-2 | (3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮 | (3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione | C23H19N3O2 | |
| 755 | 6509-19-9 | 腺嘌呤硫酸盐二水合物 | Adenine Sulfate Dihydrate | C10H16N10O6S | |
| 756 | 10318-62-4 | CYTIDYLYL(5'→2')ADENOSINE | cytidylyl(5'->2')adenosine | C19H25N8O11P | |
| 757 | 733767-34-5 | N6-[2-[[4-(二乙基氨基)-1-甲基丁基]氨基]-6-甲基-4-嘧啶基]-2-甲基-4,6-喹啉二胺 | NSC 23766 TETRAHYDROCHLORIDE | C24H35N7 | |
| 758 | 798577-91-0 | CB62731021 | BAL27862 | C20H17N7O2 | |
| 759 | 1341215-17-5 | BTTP | 3-(4-((bis((1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amino)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol | C20H34N10O | |
| 760 | 877049-90-6 | 6-TET氨基磷酸酯[5'-四氯荧光素氨基磷酸酯] | 6-TET phosphoramidite [5'-Tetrachlorofluorescein phosphoramidite] | C46H54Cl4N3O10P | |
| 761 | 1175006-92-4 | 四氢茉莉酸钠 | sodium tetrahydrojasmonate | C11H15NaO3 | |
| 762 | 1027512-13-5 | 荧光素 II CEP | Fluorescein II CEP | C67H76N3O14P | |
| 763 | 71353-94-1 | 2,2'-联吡啶-3,3'-二甲醇 | 3,3'-bis(hydroxymethyl)-2,2'-bipyridine | C12H12N2O2 | |
| 764 | 168332-12-5 | 1KG | 备注:厂家优势供应 | (S)-DMT-glycidol-T | C29H30N2O6 | |
| 765 | 2183473-20-1 | BDP 581/591 AZIDE | BDP 581/591 azide | | |
| 766 | 217075-36-0 | C11 BODIPY 581/591 | Borate(1-), difluoro[5-[[5-[(1E,3E)-4-phenyl-1,3-butadien-1-yl]-2H-pyrrol-2-ylidene-κN]methyl]-1H-pyrrole-2-undecanoato(2-)-κN1]-, hydrogen (1:1), (T-4)- | C30H34BF2N2O2.H | |
| 767 | 45172-44-9 | BOC-L-SELENOMETHIONINE | BOC-L-SELENOMETHIONINE | C10H19NO4Se | |
| 768 | 1135416-11-3 | Z-ASP-GLU-VAL-ASP-AFC: Z-DEVD-AFC | Z-DEVD-AFC | C36H38F3N5O14 | |
| 769 | 1886-13-1 | 光敏剂1 | 4,5-bis(4-dimethylaminophenyl)-2-(3,5-dimethoxy-4-hydroxyphenyl)imidazole | C27H30N4O3 | |
| 770 | 1159490-85-3 | 4-[1-(6-喹啉基甲基)-1H-1,2,3-三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-乙醇 4-羟基苯磺酸盐 | PF-04217903 | C25H22N8O5S | |
| 771 | 1207283-85-9 | TP-434 | TP-434 | C27H31FN4O8 | |
| 772 | 1360547-55-2 | 5'-六氯荧光素氨基磷酸酯 OR 5'-HEX,亚磷酰胺 | Propanoic acid, 2,2-dimethyl-, 1,1'-[6-[10-[bis(1-methylethyl)amino]-13-cyano-1-oxo-9,11-dioxa-2-aza-10-phosphatridec-1-yl]-2',4,4',5',7,7'-hexachloro-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3',6'-diyl] ester | C46H52Cl6N3O10P | |
| 773 | 2231670-91-8 | 磺酸基CY3.5活性酯 | sulfo-Cyanine3.5 NHS ester | C42H40N3O16S4(-3) | |
| 774 | 1424433-17-9 | CY3-SULFO琥珀酰亚胺酯 | Sulfo-Cyanine3 NHS ester | C34H39N3O10S2 | |
| 775 | 1355330-47-0 | 罗丹明 6G 亚磷酰胺 | R6G phosphoramidite, 6-isomer | C46H54F6N5O8P | |
| 776 | 2213445-35-1 | BDP 630/650 X NHS ESTER | BDP 630/650 X NHS ester | C33H31BF2N4O6S | |
| 777 | 1228307-80-9 | Fmoc-trans-3-Methyl-L-proline | 1,2-Pyrrolidinedicarboxylic acid, 3-methyl-, 1-(9H-fluoren-9-ylmethyl) ester, (2S,3S)- | C21H21NO4 | |
| 778 | 1417618-71-3 | 9H-Carbazole-3-carbonitrile, 9,9'-[1,1'-biphenyl]-4,4'-diylbis- | 9H-Carbazole-3-carbonitrile, 9,9'-[1,1'-biphenyl]-4,4'-diylbis- | C38H22N4 | |
| 779 | 15868-40-3 | 2-(3,5-二羟基-4-甲氧苯基)-5-羟基-3,7-二甲氧基-4H-色烯-4-酮 | 4H-1-Benzopyran-4-one, 2-(3,5-dihydroxy-4-methoxyphenyl)-5-hydroxy-3,7-dimethoxy- | C18H16O8 | |
| 780 | 6814-36-4 | 甘露糖醛酸 | Mannuronic acid | C6H10O7 | |
| 781 | 1204416-97-6 | TMC647055 | TMC-647055 | C32H38N4O6S | |
| 782 | 1219333-83-1 | BOC-7-甲基-DL-色氨酸 | BOC-7-METHYL-DL-TRYPTOPHAN | C17H22N2O4 | |